iShares U.S. ETF Trust

Copies of the annual reports transmitted to shareholders pursuant to Rule 30e-1 under the Investment Company Act of 1940 are attached.

JULY 31, 2018


2018 ANNUAL REPORT

iShares U.S. ETF Trust

LOGO iShares Evolved U.S. Consumer Staples ETF | IECS | Cboe BZX

LOGO iShares Evolved U.S. Discretionary Spending ETF | IEDI | Cboe BZX

LOGO iShares Evolved U.S. Financials ETF | IEFN | Cboe BZX

LOGO iShares Evolved U.S. Healthcare Staples ETF | IEHS | Cboe BZX

LOGO iShares Evolved U.S. Innovative Healthcare ETF | IEIH | Cboe BZX

LOGO iShares Evolved U.S. Media and Entertainment ETF | IEME | Cboe BZX

LOGO iShares Evolved U.S. Technology ETF | IETC | Cboe BZX

U.S. stocks advanced for the period from March 21, 2018, through July 31, 2018 (“reporting period”). The S&P Total Market Index™, a broad measure of U.S. equity market performance, returned 4.51% for the reporting period.

The most significant factor behind the U.S. equity market’s advance for the reporting period was an improving U.S. economy. After slowing somewhat in late 2017 and early 2018, the economy posted its fastest quarterly growth rate in four years in the second quarter of 2018. Key economic drivers included meaningful increases in consumer spending and manufacturing activity, as well as the lowest unemployment rate since April 2000.

Federal tax reform legislation also benefited stock prices. Passed in December 2017, the legislation included a steep reduction in corporate tax rates and a modest decrease in individual tax rates. Tax reform also incentivized companies to repatriate cash held outside of the U.S., raising expectations for capital spending, acquisitions, dividends, and stock repurchases by U.S. companies.

The combination of a stronger economy and lower corporate taxes contributed to record corporate profit growth across virtually all sectors of the U.S. stock market. Deregulation in selected segments of the economy and a recovery in commodities prices also benefited corporate earnings.

The improving economic environment also led to higher inflation. By the end of the reporting period, the year-over-year inflation rate had reached its highest level in more than six years. A faster inflation rate prompted the U.S. Federal Reserve Bank (“Fed”) to raise short-term interest rates twice in the first half of 2018, lifting its short-term interest rate target to its highest level in a decade. Rising inflation also resulted in broadly higher interest rates, which can lead to higher borrowing costs for companies, consumers, and the government.

Although the U.S. equity market advanced overall for the reporting period, the market faced several bouts of meaningful volatility, much of which was driven by geopolitical developments. In addition to ongoing turmoil in North Korea and the Middle East, the most significant geopolitical issue was a burgeoning trade conflict between the U.S. and several of its international trading partners. In March 2018, the U.S. government announced plans to implement tariffs on steel, aluminum, and selected Chinese products. China responded with tariffs on certain U.S. agricultural products, leading to an escalating series of tariff threats between the two countries. Meanwhile, the steel and aluminum tariffs led to trade clashes between the U.S. and Europe, Canada, and Mexico. The ensuing volatility in the U.S. stock market reflected fears of a broad trade war and corresponding economic disruption.

For the reporting period, small-capitalization stocks outperformed mid- and large-capitalization equities, reflecting an investor shift toward smaller companies with greater exposure to the U.S. economy. Signs of slowing growth in other regions of the globe, improving domestic economic activity, and the potential negative impact of a trade war on large multinational companies provided support for small-capitalization stocks.

Among large- and small-capitalization stocks, growth stocks outpaced value-oriented equities for the reporting period. In contrast, value stocks outperformed growth among mid-capitalization stocks. Overall, growth-oriented information technology companies generally benefited from an ongoing shift toward e-commerce, digital advertising, cloud computing, mobile devices, and streaming services.

The iShares Evolved U.S. Consumer Staples ETF (the “Fund”) seeks to provide access to U.S. companies with consumer staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Past performance is no guarantee of future results. Performance results do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. See “About Fund Performance” on page 20 for more information.

Consumer staples stocks rose, as U.S. economic growth and consumer spending strengthened during the abbreviated reporting period. However, gains were limited by rising interest rates, which reduced the appeal of higher-yielding staples stocks relative to bonds. Other challenges included competition from online retailers and increased pricing pressures.

In that environment, the Fund rose but underperformed the broader market, as represented by the S&P Total Market Index, for the reporting period. Performance in the staples sector is perhaps best represented by stocks in the beverages industry, such as the Coca-Cola Co. and PepsiCo Inc., which managed modest gains. These companies faced challenges from evolving consumer preferences for healthier food and drinks, particularly as it related to sugar in carbonated drinks. Nevertheless, beverage companies have found success reducing sugar content, diversifying into healthier drinks, and experimenting with new products and packaging. Food products and household products companies, such as Kellogg Co. and the Procter & Gamble Co., faced similar challenges. Such companies generally posted positive performance, though they faced pressure on pricing, changing consumer tastes, and distribution.

On the downside, tobacco companies such as Philip Morris International Inc. declined during the reporting period. Concerns about the slow adoption of smokeless tobacco products, particularly internationally and among the sizable proportion of the smoking population older than 50, weighed on performance. Investors also appeared to be concerned about uneven progress for smokeless tobacco products clearing regulatory hurdles around the globe.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer staples companies that traditionally have been categorized in sectors other than consumer staples. For example, the process grouped Monsanto Co., which has traditionally been categorized in the materials sector and associated with agricultural chemicals, in the staples sector. During the reporting period, Monsanto performed well and was acquired by a German multinational company at a premium to its stock price.

The iShares Evolved U.S. Discretionary Spending ETF (the “Fund”) seeks to provide access to U.S. companies with discretionary spending exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Stocks tied to discretionary spending benefited from a strengthening economy, as U.S. economic growth was the fastest in almost four years in the second quarter of 2018. Consumer spending, which accounts for more than two-thirds of the economy, drove economic growth as personal spending rose 0.4% in June.

The Fund outperformed the broader market, as represented by the S&P Total Market Index, for the abbreviated reporting period. While improving economic conditions led to more consumer spending, technological changes also affected performance of retail-centered stocks. For example, the ongoing “retail apocalypse” (the evolution away from traditional brick-and-mortar retailers to online shopping) is perhaps most well reflected in the strong advance of online retail giant Amazon.com Inc. Other solid performers included companies addressing specific markets segments, like the Home Depot Inc., which benefited from the ongoing recovery in the housing market. Similarly, select companies with globally recognized brands, such as Nike Inc., also performed well. Finally, off-price retailers were some of the leading performers. This included the TJX Companies Inc., the parent company for discount retailers T.J .Maxx and Marshalls, among others.

On the downside, fast-casual restaurants such as Starbucks Corp. declined during the reporting period. Concerns about intense price competition, as well as changing customer tastes and health concerns, led to weakness in some restaurant chains. Slower-than-expected growth in the U.S. and in international markets such as China, also weighed on a number of restaurant stocks.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several consumer discretionary companies with similar exposure to others in discretionary spending that traditionally have been categorized in other sectors. For example, the process grouped Costco Wholesale Corp., which has traditionally been categorized in the food and staples retail industry, with the discretionary spending sector. During the reporting period, Costco performed well, benefiting from the strength in consumer spending as its growing digital business and membership model allowed it to succeed in a competitive retail landscape.

The iShares Evolved U.S. Financials ETF (the “Fund”) seeks to provide access to U.S. companies with financials exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The Fund NAV total return presented in the table for the since inception period differs from the same period return disclosed in the financial highlights. The total return in the financial highlights is calculated in the same manner but differs due to certain adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

Financials stocks declined during the abbreviated reporting period, even as U.S. economic growth was the fastest in almost four years in the second quarter of 2018. Nevertheless, performance of financials stocks was muted amid concerns about a flattening yield curve and potential disruption to economic activity from a brewing trade war. A flatter yield curve means the difference in yield between short- and long-term securities declines, negatively affecting bank profitability. Investors were also concerned that these yield curve changes signaled slower growth ahead.

In that environment, the Fund declined and underperformed the broader market, as represented by the S&P Total Market Index, for the reporting period. Diversified banks were symptomatic of the general tension around the performance of financials stocks. Companies such as JPMorgan Chase &Co. and Bank of America Corp. posted negative returns in the

Fund, while others, such as Wells Fargo & Co., rose. In addition to facing concerns about a possible slowdown in growth and changes in the shape of the yield curve, these large banks were subject to tests of their financial health by the Fed. While the outcomes of these “stress tests” were generally positive, investors were disappointed that a number of leading banks were forced to scale back or cancel planned increases in dividend payouts. It was a similar story for asset managers and custody banks, such as State Street Corp., and investment bankers and brokerages, including Morgan Stanley and the Goldman Sachs Group Inc., which also faced capital controls from Fed regulators.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several financial companies that have traditionally been categorized in other sectors. For example, the process grouped Mastercard Inc., which has traditionally been categorized in the software and services industry, in the financials sector. Mastercard performed well, benefiting from strong consumer spending and purchases, as well as the shift away from cash and check to digital payments.

The iShares Evolved U.S. Healthcare Staples ETF (the “Fund”) seeks to provide access to U.S. companies with healthcare staples exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

U.S. healthcare staples stocks continued to benefit from an aging population, which has led to increased demand for healthcare products and services. Since the first Baby Boomers reached age 65 in early 2011, about 10,000 people per day have turned 65 in the U.S., driving overall spending on healthcare higher.

The Fund outperformed the broader market, as represented by the S&P Total Market Index, for the abbreviated reporting period. The aging population drove strong growth in the Medicare Advantage plans offered by private health insurance companies, which helped support managed care stocks such as UnitedHealth Group Inc. Healthcare equipment companies such as Boston Scientific Corp. and Intuitive Surgical Inc. were also solid performers, benefiting from new technological developments and the delay of a federal excise tax on medical devices. Other noteworthy performers among healthcare staples stocks included life sciences companies such as Illumina Inc. and healthcare facilities operators such as HCA Healthcare Inc. Many life sciences stocks generated stronger-than-expected earnings during the reporting period. Meanwhile, healthcare facilities companies benefited from solid operational performance and a lower corporate tax rate resulting from the 2017 federal tax reform legislation.

On the downside, healthcare distributors such as Cardinal Health Inc. declined during the reporting period. Price reductions in generic drugs led to narrowing profit margins, and concerns about new competitors from outside the industry weighed on the stock prices of healthcare distributors.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. More specifically, the evolved investment process identified companies with healthcare staples businesses that have traditionally been categorized into other sectors. For example, drug retailers have traditionally been classified as consumer staples stocks, yet have elements in common with other traditionally classified healthcare companies. In addition, many drug retailers have expanded into other healthcare segments, including pharmacy benefits management and health insurance. Drug retailers advanced for the reporting period, as increased prescription volumes drove revenue and earnings growth.

The iShares Evolved U.S. Innovative Healthcare ETF (the “Fund”) seeks to provide access to U.S. companies with innovative healthcare exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

U.S. innovative healthcare stocks continued to benefit from an aging population, which has led to increased demand for healthcare products and services. Since the first Baby Boomers reached age 65 in early 2011, about 10,000 people per day have turned 65 in the U.S., driving overall spending on healthcare higher. New technological developments — including robotics, miniaturization, and AI-related analytical tools — have been a source of both innovation and growth for healthcare-related companies.

The Fund slightly outperformed the broader market, as represented by the S&P Total Market Index, for the abbreviated reporting period. The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. As of the end of the reporting period, the Fund’s portfolio consisted primarily of pharmaceutical and biotechnology companies, but also included companies in diverse industries such as medical devices, electronic equipment, and semiconductor manufacturing.

Pharmaceutical stocks such as Eli Lilly & Co., Merck & Co. Inc., and Pfizer Inc. benefited from strong demand for medications from an aging population, including drugs that treat diabetes and various forms of cancer, as well as vaccines to protect the elderly from health problems such as pneumonia and meningitis. In addition, a robust new product development pipeline, with a number of potential blockbuster medications in late-stage clinical trials, helped support pharmaceutical stocks. Biotechnology companies such as Biogen Inc. were also solid performers, benefiting from several new product launches and an increase in mergers and acquisitions. Healthcare equipment makers also advanced, supported by the development of innovative new technologies and the delay of a federal excise tax on medical devices.

On the downside, several pharmaceutical and biotechnology stocks declined meaningfully during the reporting period. For example, biotechnology company AbbVie Inc. weakened amid concerns about potential regulatory changes for biosimilars, or generic biopharmaceuticals, and drug rebates.

The iShares Evolved U.S. Media and Entertainment ETF (the “Fund”) seeks to provide access to U.S. companies with media and entertainment exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

U.S. media and entertainment stocks advanced amid a rapidly changing landscape. Historically, studios produced content, such as television shows and movies, which was sold to distributors, such as broadcast networks and movie theaters. The distributors would then make the content available to consumers. Today, there are a wider variety of distribution platforms, and many distribution companies are creating and delivering their own content. A spate of recent mergers and acquisitions have further blurred the lines between content providers and distributors, and a number of new players — from technology to telecommunications companies — are establishing a presence in the industry.

The Fund outperformed the broader market, as represented by the S&P Total Market Index, for the reporting period. Merger activity and strong film franchises helped support movie producers such as Twenty-First Century Fox Inc. and the Walt Disney Co. Broadcast network companies such as Discovery Inc. also benefited from industry consolidation, as well as from strong growth in licensing fees for streaming services. Entertainment companies like World Wrestling Entertainment Inc. were strong performers amid new licensing deals with a variety of content distributors.

On the downside, cable and satellite companies such as DISH Network Corp. declined. Increased competition and a continuation of the “cord-cutting”— consumers shifting away from traditional subscription-based cable television to streaming and other content delivery systems — weighed on cable and satellite stocks.

The Fund’s evolved investment process looks beyond traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. More specifically, the evolved investment process identified several companies with media and entertainment businesses that have traditionally been categorized into other sectors. For example, Netflix Inc. has traditionally been considered an internet and direct marketing company in the retail industry. However, Netflix has become a significant content developer and distributor, competing directly with traditional media and entertainment companies. Netflix advanced for the reporting period as strong subscriber additions drove accelerating revenue growth and profitability.

The iShares Evolved U.S. Technology ETF (the “Fund”) seeks to provide access to U.S. companies with technology exposure, as classified using a proprietary classification system. The Fund is an actively managed exchange-traded fund that does not seek to replicate the performance of a specified index.

For the fiscal period ended 7/31/18, the Fund did not have six months of performance and therefore line graphs are not presented.

The inception date of the Fund was 3/21/18. The first day of secondary market trading was 3/23/18.

The S&P Total Market Index^TM is an unmanaged index designed to track the broad equity market, including large-, mid-, small-, and micro-cap stocks.

The increase in capital raised in technology initial public offerings (“IPOs”) reflected a relatively solid environment for U.S. technology stocks. While IPOs grew at a modest pace in 2017, activity increased in the second quarter of 2018 as more companies went public than in any quarter in the previous three years. Online retail, digital advertising, cloud computing, and streaming video continued to drive growth in the technology sector. Investors’ expectations for growth in artificial intelligence (“AI”), blockchain, and connected devices also benefited U.S. technology stocks.

For the reporting period, the Fund outperformed the broader market, as represented by the S&P Total Market Index. Growth in cloud-based services and AI and machine-learning solutions benefited software and services stocks, such as Microsoft Corp. and Alphabet Inc., as businesses implemented software solutions to improve customer service and business efficiency. Consumers continued to spend more time on mobile devices than on television, which led to growth in digital advertising for many software companies. Online shopping also increased the use of digital payments, benefiting companies like Visa Inc.

Technology hardware and equipment stocks, such as Apple Inc., advanced as new smartphone models allayed investors’ concerns about a broader slowdown in smartphone sales. On the downside, International Business Machines Corp. declined for the reporting period. The company struggled to develop innovative and effective technologies after making major investments in AI and machine learning.

The Fund’s evolved investment process looks beyond the traditional sector definitions by applying machine learning and natural language processing to group individual companies with related business activity. During the reporting period, the evolved process identified several technology companies with similar businesses that have traditionally been categorized in other sectors. For example, Amazon.com Inc. is often grouped with traditional retail stores. The company advanced as it continued to leverage AI and machine learning to capture market share from traditional retailers while expanding its cloud-computing services. Amazon.com also gained market share in digital advertising, as retailers boosted spending on digital display ads.

Past performance is no guarantee of future results. Current performance may be lower or higher than the performance data quoted. Performance data current to the most recent month-end is available at www.ishares.com. Performance results assume reinvestment of all dividends and capital gain distributions and do not reflect the deduction of taxes that a shareholder would pay on fund distributions or on the redemption or sale of fund shares. The investment return and principal value of shares will vary with changes in market conditions. Shares may be worth more or less than their original cost when they are redeemed or sold in the market. Performance for certain funds may reflect a waiver of a portion of investment advisory fees. Without such a waiver, performance would have been lower.

Net asset value or “NAV” is the value of one share of a fund as calculated in accordance with the standard formula for valuing mutual fund shares. The price used to calculate market return (“Market Price”) is determined by using the midpoint between the highest bid and the lowest ask on the primary stock exchange on which shares of a fund are listed for trading, as of the time that such fund’s NAV is calculated. Since shares of a fund may not trade in the secondary market until after the fund’s inception, for the period from inception to the first day of secondary market trading in shares of the fund, the NAV of the fund is used as a proxy for the Market Price to calculate market returns. Market and NAV returns assume that dividends and capital gain distributions have been reinvested at Market Price and NAV, respectively.

An index is a statistical composite that tracks a specified financial market or sector. Unlike a fund, an index does not actually hold a portfolio of securities and therefore does not incur the expenses incurred by a fund. These expenses negatively impact fund performance. Also, market returns do not include brokerage commissions that may be payable on secondary market transactions. If brokerage commissions were included, market returns would be lower.

As a shareholder of your Fund, you incur two types of costs: (1) transaction costs, including brokerage commissions on purchases and sales of fund shares and (2) ongoing costs, including management fees and other fund expenses. The expense example, which is based on an investment of $1,000 invested at the beginning of the period (or from the commencement of operations if less than 6 months) and held through the end of the period, is intended to help you understand your ongoing costs (in dollars and cents) of investing in your Fund and to compare these costs with the ongoing costs of investing in other funds.

Actual Expenses – The table provides information about actual account values and actual expenses. Annualized expense ratios reflect contractual and voluntary fee waivers, if any. To estimate the expenses that you paid on your account over the period, simply divide your account value by $1,000 (for example, an $8,600 account value divided by $1,000 = 8.6), then multiply the result by the number under the heading entitled “Expenses Paid During the Period.”

Hypothetical Example for Comparison Purposes – The table also provides information about hypothetical account values and hypothetical expenses based on your Fund’s actual expense ratio and an assumed rate of return of 5% per year before expenses. You may use this information to compare the ongoing costs of investing in your Fund and other funds. To do so, compare this 5% hypothetical example with the 5% hypothetical examples that appear in the shareholder reports of the other funds.

Please note that the expenses shown in the table are meant to highlight your ongoing costs only and do not reflect any transactional costs, such as brokerage commissions paid on purchases and sales of fund shares. Therefore, the hypothetical examples are useful in comparing ongoing costs only and will not help you determine the relative total costs of owning different funds. In addition, if these transactional costs were included, your costs would have been higher.


Security	Shares		Value

Common Stocks

Advertising — 0.1%
Omnicom Group Inc.		48	$	3,304


Agriculture — 12.7%
Altria Group Inc.		3,045		178,681
Archer-Daniels-Midland Co.		1,290		62,255
Philip Morris International Inc.		2,682		231,457
Universal Corp./VA		63		4,353
Vector Group Ltd.		102		1,882

				478,628

Beverages — 26.3%
Boston Beer Co. Inc. (The), Class A, NVS^(a)		18		4,949
Brown-Forman Corp., Class A		210		11,187
Brown-Forman Corp., Class B, NVS		681		36,243
Coca-Cola Co. (The)		8,049		375,325
Constellation Brands Inc., Class A		399		83,882
Keurig Dr Pepper Inc.		654		15,703
MGP Ingredients Inc.		33		2,708
Molson Coors Brewing Co., Class B		450		30,150
Monster Beverage Corp.^(a)		1,521		91,290
National Beverage Corp.^(a)		45		4,748
PepsiCo Inc.		2,886		331,890

				988,075

Biotechnology — 0.1%
Incyte Corp.^(a)		27		1,797


Chemicals — 1.0%
Balchem Corp.		33		3,309
FMC Corp.		117		10,516
International Flavors & Fragrances Inc.		147		19,516
Sensient Technologies Corp.		72		4,994

				38,335

Commercial Services — 0.6%
Ecolab Inc.		120		16,884
Nutrisystem Inc.		45		1,800
Weight Watchers International Inc.^(a)		27		2,417

				21,101

Computers — 0.1%
HP Inc.		165		3,808


Cosmetics & Personal Care — 9.1%
Colgate-Palmolive Co.		1,593		106,747
Coty Inc., Class A		528		7,081
Edgewell Personal Care Co.^(a)		75		4,040
Estee Lauder Companies Inc. (The), Class A		81		10,930
Procter & Gamble Co. (The)		2,613		211,339

				340,137

Distribution & Wholesale — 0.0%
Core-Mark Holding Co. Inc.		69		1,668


Diversified Financial Services — 0.3%
CME Group Inc.		54		8,592
Jefferies Financial Group Inc.		114		2,765

				11,357

Electric — 0.2%
Entergy Corp.		111		9,022


Electrical Components & Equipment — 0.1%
Energizer Holdings Inc.		84		5,349


Security	Shares		Value

Food — 26.7%
B&G Foods Inc.^(b)		231	$	7,253
Calavo Growers Inc.		33		3,053
Cal-Maine Foods Inc.^(a)(b)		60		2,700
Campbell Soup Co.		639		26,135
Conagra Brands Inc.		1,326		48,677
Darling Ingredients Inc.^(a)		261		5,244
Dean Foods Co.		243		2,386
Flowers Foods Inc.		357		7,283
General Mills Inc.		2,106		97,002
Hain Celestial Group Inc. (The)^(a)		312		8,873
Hershey Co. (The)		465		45,668
Hormel Foods Corp.		723		26,006
Hostess Brands Inc.^(a)		195		2,732
Ingredion Inc.		171		17,322
J&J Snack Foods Corp.		39		5,653
JM Smucker Co. (The)		375		41,670
John B Sanfilippo & Son Inc.		27		2,075
Kellogg Co.		987		70,107
Kraft Heinz Co. (The)		2,340		140,985
Lamb Weston Holdings Inc.		387		27,195
Lancaster Colony Corp.		51		7,397
McCormick & Co. Inc./MD, NVS		303		35,615
Mondelez International Inc., Class A		4,425		191,957
Performance Food Group Co.^(a)		138		4,947
Pilgrim’s Pride Corp.^(a)		90		1,604
Pinnacle Foods Inc.		351		23,313
Post Holdings Inc.^(a)		219		18,957
Sanderson Farms Inc.		36		3,630
Sprouts Farmers Market Inc.^(a)		135		2,901
Sysco Corp.		822		55,247
Tootsie Roll Industries Inc.		42		1,256
TreeHouse Foods Inc.^(a)		192		9,118
Tyson Foods Inc., Class A		828		47,734
U.S. Foods Holding Corp.^(a)		303		10,244
United Natural Foods Inc.^(a)		66		2,125

				1,004,064

Holding Companies - Diversified — 0.1%
Spectrum Brands Holdings Inc.^(a)		21		1,835


Home Furnishings — 0.2%
Whirlpool Corp.		42		5,506


Household Products & Wares — 2.2%
ACCO Brands Corp.		93		1,190
Central Garden & Pet Co., Class A, NVS^(a)		39		1,565
Church & Dwight Co. Inc.		309		17,273
Clorox Co. (The)		123		16,626
Kimberly-Clark Corp.		387		44,064

				80,718

Housewares — 0.1%
Scotts Miracle-Gro Co. (The)		42		3,336
Tupperware Brands Corp.		48		1,762

				5,098

Machinery — 0.2%
AGCO Corp.		69		4,348
Middleby Corp. (The)^(a)		27		2,767

				7,115

Manufacturing — 0.2%
AptarGroup Inc.		27		2,766


Security	Shares		Value

Manufacturing (continued)
John Bean Technologies Corp.		36	$	3,981

				6,747

Oil & Gas — 0.2%
Valero Energy Corp.		78		9,231


Packaging & Containers — 1.6%
Ball Corp.		627		24,434
Bemis Co. Inc.		135		6,198
Crown Holdings Inc.^(a)		246		11,136
Owens-Illinois Inc.^(a)		234		4,371
Packaging Corp. of America		15		1,694
Sealed Air Corp.		78		3,438
Silgan Holdings Inc.		111		3,054
Sonoco Products Co.		126		7,033

				61,358

Pharmaceuticals — 1.3%
Neogen Corp.^(a)		81		6,674
Prestige Brands Holdings Inc.^(a)		66		2,358
Zoetis Inc.		474		40,992

				50,024

Retail — 10.7%
Casey’s General Stores Inc.		33		3,610
Cheesecake Factory Inc. (The)		42		2,353
Chipotle Mexican Grill Inc.^(a)		42		18,214
Costco Wholesale Corp.		183		40,024
Darden Restaurants Inc.		105		11,229
Dunkin’ Brands Group Inc.		117		8,147
Jack in the Box Inc.		27		2,274
McDonald’s Corp.		918		144,622
Starbucks Corp.		2,235		117,092
Walmart Inc.		150		13,384
Wendy’s Co. (The)		90		1,501
Wingstop Inc.		27		1,332
Yum China Holdings Inc.		330		11,906
Yum! Brands Inc.		306		24,263

				399,951


Security	Shares		Value

Software — 0.2%
Activision Blizzard Inc.		99	$	7,269


Toys, Games & Hobbies — 0.3%
Hasbro Inc.		39		3,885
Mattel Inc.		357		5,665

				9,550


Total Common Stocks — 94.6% (Cost: $3,533,593)				3,551,047


Short-Term Investments

Money Market Funds — 5.6%
BlackRock Cash Funds: Institutional, SL Agency Shares, 2.14%^(c)(d)(e)		10,250		10,253
BlackRock Cash Funds: Treasury, SL Agency Shares, 1.83%^(c)(d)		200,121		200,121

				210,374


Total Short-Term Investments — 5.6% (Cost: $210,374)				210,374


Total Investments in Securities — 100.2% (Cost: $3,743,967)				3,761,421

Other Assets, Less Liabilities — (0.2)%				(6,181	)


Net Assets — 100.0%			$	3,755,240

^(a)	Non-income producing security.

^(b)	All or a portion of this security is on loan.

^(c)	Affiliate of the Fund.

^(d)	Annualized 7-day yield as of period-end.

^(e)	All or a portion of this security was purchased with cash collateral received from loaned securities.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Affiliated Issuer	Shares Held at 03/21/18	^(a)	Net Activity	Shares Held at 07/31/18		Value at 07/31/18		Income			Net Realized Gain (Loss)	^(b)		Change in Unrealized Appreciation (Depreciation)
BlackRock Cash Funds: Institutional, SL Agency Shares	—		10,250	10,250	$	10,253	$	8	^(c)	$	—		$	—
BlackRock Cash Funds: Treasury, SL Agency Shares	—		200,121	200,121		200,121		581			—			—

					$	210,374	$	589		$	—		$	—

Various inputs are used in determining the fair value of financial instruments. For description of the input levels and information about the Fund’s policy regarding valuation of financial instruments, refer to the Notes to Financial Statements.

The following table summarizes the value of the Fund’s investments according to the fair value hierarchy as of July 31, 2018. The breakdown of the Fund’s investments into major categories is disclosed in the Schedule of Investments above.


	Level 1		Level 2		Level 3		Total
Investments
Assets
Common Stocks	$	3,551,047	$	—	$	—	$	3,551,047
Money Market Funds		210,374		—		—		210,374

	$	3,761,421	$	—	$	—	$	3,761,421


Security	Shares		Value

Common Stocks

Airlines — 0.2%
Alaska Air Group Inc.		104	$	6,535
JetBlue Airways Corp.^(a)		276		4,968

				11,503

Apparel — 7.8%
Carter’s Inc.		140		14,676
Columbia Sportswear Co.		72		6,263
Crocs Inc.^(a)		136		2,463
Deckers Outdoor Corp.^(a)		84		9,478
Hanesbrands Inc.		736		16,383
NIKE Inc., Class B		2,644		203,350
Oxford Industries Inc.		48		4,422
PVH Corp.		204		31,318
Ralph Lauren Corp.		140		18,897
Skechers U.S.A. Inc., Class A^(a)		336		9,314
Steven Madden Ltd.		148		7,999
Under Armour Inc., Class A^(a)		404		8,068
Under Armour Inc., Class C, NVS^(a)		412		7,721
VF Corp.		784		72,183
Wolverine World Wide Inc.		124		4,387

				416,922

Building Materials — 0.1%
American Woodmark Corp.^(a)		16		1,334
Masco Corp.		104		4,195

				5,529

Chemicals — 0.1%
Valvoline Inc.		168		3,795


Commercial Services — 1.3%
Aaron’s Inc.		144		6,237
Avis Budget Group Inc.^(a)		68		2,370
Bright Horizons Family Solutions Inc.^(a)		20		2,140
Brink’s Co. (The)		36		2,875
Cintas Corp.		72		14,722
Euronet Worldwide Inc.^(a)		40		3,678
Grand Canyon Education Inc.^(a)		36		4,195
H&R Block Inc.		224		5,636
ManpowerGroup Inc.		60		5,595
Monro Inc.		68		4,586
Rollins Inc.		80		4,395
ServiceMaster Global Holdings Inc.^(a)		136		7,751
Sotheby’s^(a)		36		1,912
Weight Watchers International Inc.^(a)		36		3,223

				69,315

Computers — 0.5%
Apple Inc.		148		28,163


Cosmetics & Personal Care — 5.0%
Coty Inc., Class A		344		4,613
Estee Lauder Companies Inc. (The), Class A		364		49,118
Procter & Gamble Co. (The)		2,628		212,553

				266,284

Distribution & Wholesale — 1.3%
Fastenal Co.		380		21,633
G-III Apparel Group Ltd.^(a)		116		5,301
HD Supply Holdings Inc.^(a)		124		5,454
KAR Auction Services Inc.		96		5,707
LKQ Corp.^(a)		204		6,838
Pool Corp.		44		6,743


Security	Shares		Value

Distribution & Wholesale (continued)
SiteOne Landscape Supply Inc.^(a)		36	$	3,210
WW Grainger Inc.		48		16,635

				71,521

Diversified Financial Services — 0.2%
Alliance Data Systems Corp.		36		8,096
LendingTree Inc.^(a)		4		955

				9,051

Entertainment — 1.0%
Cinemark Holdings Inc.		128		4,598
Eldorado Resorts Inc.^(a)		80		3,428
Live Nation Entertainment Inc.^(a)		180		8,870
Madison Square Garden Co. (The), Class A^(a)		20		6,244
Marriott Vacations Worldwide Corp.		24		2,859
Pinnacle Entertainment Inc.^(a)		60		1,994
Red Rock Resorts Inc., Class A		116		4,099
Scientific Games Corp./DE, Class A^(a)		44		2,114
Six Flags Entertainment Corp.		68		4,417
Vail Resorts Inc.		52		14,397

				53,020

Food — 2.2%
Flowers Foods Inc.		180		3,672
Kroger Co. (The)		2,420		70,180
Performance Food Group Co.^(a)(b)		128		4,589
Sprouts Farmers Market Inc.^(a)		252		5,415
Sysco Corp.		364		24,464
U.S. Foods Holding Corp.^(a)		216		7,303
United Natural Foods Inc.^(a)		68		2,190

				117,813

Food Service — 0.2%
Aramark		320		12,868


Hand & Machine Tools — 0.0%
Snap-on Inc.		16		2,713


Holding Companies - Diversified — 0.0%
Spectrum Brands Holdings Inc.^(a)(b)		16		1,398


Home Builders — 0.2%
PulteGroup Inc.		172		4,900
Taylor Morrison Home Corp., Class A^(a)		80		1,563
Toll Brothers Inc.		104		3,667

				10,130

Home Furnishings — 0.1%
Sleep Number Corp.^(a)		68		1,938
Tempur Sealy International Inc.^(a)(b)		68		3,323

				5,261

Household Products & Wares — 0.3%
Kimberly-Clark Corp.		128		14,574


Housewares — 0.3%
Newell Brands Inc.		432		11,314
Scotts Miracle-Gro Co. (The)		32		2,542
Tupperware Brands Corp.		44		1,615

				15,471

Internet — 14.9%
Amazon.com Inc.^(a)		344		611,440
Booking Holdings Inc.^(a)		56		113,608
Cars.com Inc.^(a)		60		1,702
eBay Inc.^(a)		332		11,106
Etsy Inc.^(a)		116		4,740


Security	Shares		Value

Internet (continued)
Expedia Group Inc.		52	$	6,960
Groupon Inc.^(a)		484		2,265
GrubHub Inc.^(a)		88		10,726
Liberty Expedia Holdings Inc., Class A^(a)		64		3,083
MercadoLibre Inc.		44		15,088
Shutterfly Inc.^(a)		28		2,303
Stamps.com Inc.^(a)		12		3,132
TripAdvisor Inc.^(a)		100		5,799
Wayfair Inc., Class A^(a)		72		7,835

				799,787

Leisure Time — 0.8%
Carnival Corp.		556		32,937
Planet Fitness Inc., Class A^(a)		208		9,884
Polaris Industries Inc.		28		2,952

				45,773

Lodging — 3.6%
Boyd Gaming Corp.^(b)		96		3,586
Caesars Entertainment Corp.^(a)(b)		156		1,763
Choice Hotels International Inc.		64		4,966
Extended Stay America Inc.		172		3,662
Hilton Grand Vacations Inc.^(a)		84		2,905
Hilton Worldwide Holdings Inc.		344		27,059
Hyatt Hotels Corp., Class A		64		5,007
ILG Inc.		140		4,806
Las Vegas Sands Corp.		496		35,662
Marriott International Inc./MD, Class A		392		50,113
MGM Resorts International		572		17,944
Wyndham Destinations Inc.		164		7,564
Wyndham Hotels & Resorts Inc.		164		9,512
Wynn Resorts Ltd.		100		16,678

				191,227

Machinery — 0.1%
Middleby Corp. (The)^(a)		20		2,050
Welbilt Inc.^(a)		100		2,280

				4,330

Office Furnishings — 0.0%
Herman Miller Inc.		48		1,817


Oil & Gas — 0.1%
Murphy USA Inc.^(a)		48		3,804


Pharmaceuticals — 0.3%
CVS Health Corp.		292		18,939


Real Estate — 0.1%
RE/MAX Holdings Inc., Class A		28		1,422
Realogy Holdings Corp.		100		2,187

				3,609

Real Estate Investment Trusts — 1.4%
Apple Hospitality REIT Inc.		168		3,022
CorePoint Lodging Inc.^(a)		78		1,970
Host Hotels & Resorts Inc.		532		11,140
Macerich Co. (The)		104		6,142
Park Hotels & Resorts Inc.		120		3,754
Ruth’s Hospitality Group Inc.		72		2,084
Ryman Hospitality Properties Inc.		32		2,720
Tailored Brands Inc.		140		2,823
Tanger Factory Outlet Centers Inc.		120		2,862
Tapestry Inc.		740		34,869


Security	Shares		Value

Real Estate Investment Trusts (continued)
Taubman Centers Inc.		72	$	4,468

				75,854

Retail — 56.1%
Abercrombie & Fitch Co., Class A		184		4,359
Advance Auto Parts Inc.		168		23,727
American Eagle Outfitters Inc.		468		11,784
AutoNation Inc.^(a)		84		4,076
AutoZone Inc.^(a)		60		42,332
Beacon Roofing Supply Inc.^(a)		48		2,020
Bed Bath & Beyond Inc.		380		7,117
Best Buy Co. Inc.		540		40,516
Big Lots Inc.		124		5,385
BJ’s Restaurants Inc.		36		2,277
Bloomin’ Brands Inc.		192		3,713
Brinker International Inc.		116		5,472
Buckle Inc. (The)		76		1,828
Burlington Stores Inc.^(a)		196		29,951
Caleres Inc.		100		3,349
CarMax Inc.^(a)		272		20,313
Casey’s General Stores Inc.		84		9,188
Cheesecake Factory Inc. (The)		84		4,707
Chico’s FAS Inc.		384		3,341
Children’s Place Inc. (The)		56		6,882
Chipotle Mexican Grill Inc.^(a)		44		19,081
Copart Inc.^(a)		72		4,132
Costco Wholesale Corp.		1,016		222,209
Cracker Barrel Old Country Store Inc.		56		8,204
Darden Restaurants Inc.		268		28,660
Dave & Buster’s Entertainment Inc.^(a)		108		5,308
Denny’s Corp.^(a)		144		2,095
Dick’s Sporting Goods Inc.		208		7,101
Dillard’s Inc., Class A^(b)		36		2,890
Dine Brands Global Inc.		44		3,125
Dollar General Corp.		704		69,098
Dollar Tree Inc.^(a)		704		64,261
Domino’s Pizza Inc.		104		27,317
DSW Inc., Class A		192		5,269
Dunkin’ Brands Group Inc.		100		6,963
Express Inc.^(a)		240		2,311
FirstCash Inc.		76		6,171
Five Below Inc.^(a)		156		15,157
Floor & Decor Holdings Inc., Class A^(a)		72		3,438
Foot Locker Inc.		256		12,495
GameStop Corp., Class A		212		3,055
Gap Inc. (The)		696		20,998
Genesco Inc.^(a)		56		2,279
Genuine Parts Co.		124		12,067
Guess? Inc.		140		3,172
Home Depot Inc. (The)		2,560		505,651
Jack in the Box Inc.		64		5,391
JC Penney Co. Inc.^(a)(b)		548		1,343
Kohl’s Corp.		488		36,049
L Brands Inc.		760		24,069
La-Z-Boy Inc.		72		2,196
Lithia Motors Inc., Class A		28		2,493
Lowe’s Companies Inc.		1,580		156,957
Lululemon Athletica Inc.^(a)		284		34,066
Macy’s Inc.		672		26,699
McDonald’s Corp.		1,296		204,172
Michaels Companies Inc. (The)^(a)		336		6,858


Security	Shares		Value

Retail (continued)
MSC Industrial Direct Co. Inc., Class A		40	$	3,385
Nordstrom Inc.		280		14,675
Office Depot Inc.		956		2,400
Ollie’s Bargain Outlet Holdings Inc.^(a)		124		8,618
O’Reilly Automotive Inc.^(a)		200		61,200
Papa John’s International Inc.		60		2,518
PriceSmart Inc.		56		4,578
RH^(a)(b)		56		7,608
Rite Aid Corp.^(a)(b)		1,812		3,642
Ross Stores Inc.		1,100		96,173
Sally Beauty Holdings Inc.^(a)		324		5,343
Sonic Corp.		68		2,390
Starbucks Corp.		1,880		98,493
Target Corp.		1,496		120,697
Texas Roadhouse Inc.		144		9,049
Tiffany & Co.		256		35,215
TJX Companies Inc. (The)		1,708		166,120
Tractor Supply Co.		332		25,909
Ulta Salon Cosmetics & Fragrance Inc.^(a)		160		39,102
Urban Outfitters Inc.^(a)		200		8,880
Walgreens Boots Alliance Inc.		1,260		85,201
Walmart Inc.		3,468		309,450
Wendy’s Co. (The)		340		5,671
Williams-Sonoma Inc.		228		13,336
Wingstop Inc.		48		2,369
Yum China Holdings Inc.		764		27,565
Yum! Brands Inc.		724		57,406

				3,012,130

Software — 0.1%
CDK Global Inc.		84		5,246


Textiles — 0.0%
UniFirst Corp./MA		16		2,994


Security	Shares		Value

Toys, Games & Hobbies — 0.3%
Hasbro Inc.		96	$	9,563
Mattel Inc.		312		4,951

				14,514

Transportation — 0.8%
FedEx Corp.		168		41,306


Total Common Stocks — 99.4%
(Cost: $4,929,133)				5,336,661


Short-Term Investments

Money Market Funds — 1.1%
BlackRock Cash Funds: Institutional, SL Agency Shares, 2.14%^(c)(d)(e)		29,994		30,003
BlackRock Cash Funds: Treasury, SL Agency Shares, 1.83%^(c)(d)		28,996		28,996

				58,999


Total Short-Term Investments — 1.1%
(Cost: $58,996)				58,999


Total Investments in Securities — 100.5%
(Cost: $4,988,129)				5,395,660

Other Assets, Less Liabilities — (0.5)%				(26,780	)


Net Assets — 100.0%			$	5,368,880

^(a)	Non-income producing security.

^(b)	All or a portion of this security is on loan.

^(c)	Affiliate of the Fund.

^(d)	Annualized 7-day yield as of period-end.

^(e)	All or a portion of this security was purchased with cash collateral received from loaned securities.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Affiliated Issuer	Shares Held at 03/21/18	^(a)	Net Activity	Shares Held at 07/31/18		Value at 07/31/18		Income			Net Realized Gain (Loss)	^(b)		Change in Unrealized Appreciation (Depreciation)
BlackRock Cash Funds: Institutional, SL Agency Shares	—		29,994	29,994	$	30,003	$	57	^(c)	$	1		$	3
BlackRock Cash Funds: Treasury, SL Agency Shares	—		28,996	28,996		28,996		178			—			—

					$	58,999	$	235		$	1		$	3


Security	Shares		Value

Common Stocks

Banks — 46.5%
Ameris Bancorp		64	$	2,982
Associated Banc-Corp.		347		9,369
BancFirst Corp.		46		2,857
Bank of America Corp.		7,496		231,476
Bank of Hawaii Corp.		94		7,566
Bank of New York Mellon Corp. (The)		1,485		79,403
Bank OZK		234		9,571
BankUnited Inc.		216		8,394
Banner Corp.		52		3,274
BB&T Corp.		1,462		74,284
BOK Financial Corp.		53		5,159
Boston Private Financial Holdings Inc.		128		1,843
Bryn Mawr Bank Corp.		63		3,078
Capital One Financial Corp.		764		72,060
Cathay General Bancorp.		180		7,486
CenterState Bank Corp.		173		4,801
Chemical Financial Corp.		147		8,350
CIT Group Inc.		196		10,374
Citizens Financial Group Inc.		874		34,768
City Holding Co.		40		3,219
Columbia Banking System Inc.		153		6,262
Comerica Inc.		314		30,439
Commerce Bancshares Inc./MO		191		12,759
Community Bank System Inc.		114		7,211
ConnectOne Bancorp. Inc.		76		1,885
Cullen/Frost Bankers Inc.		118		13,038
CVB Financial Corp.		244		5,836
Eagle Bancorp. Inc.^(a)		67		3,621
East West Bancorp. Inc.		288		18,645
Enterprise Financial Services Corp.		58		3,263
FCB Financial Holdings Inc., Class A^(a)		84		4,284
Fifth Third Bancorp.		1,316		38,940
First BanCorp./Puerto Rico^(a)		384		3,156
First Bancorp./Southern Pines NC		71		2,941
First Busey Corp.		112		3,553
First Citizens BancShares Inc./NC, Class A		15		6,102
First Commonwealth Financial Corp.		268		4,521
First Financial Bancorp.		210		6,374
First Financial Bankshares Inc.		142		8,037
First Hawaiian Inc.		121		3,419
First Horizon National Corp.		652		11,664
First Interstate BancSystem Inc., Class A		83		3,581
First Midwest Bancorp. Inc.		230		6,134
FNB Corp./PA		695		8,917
Fulton Financial Corp.		382		6,628
Glacier Bancorp. Inc.		173		7,387
Goldman Sachs Group Inc. (The)		603		143,170
Great Western Bancorp. Inc.		127		5,315
Hancock Whitney Corp.		169		8,492
Hanmi Financial Corp.		79		1,979
Heartland Financial USA Inc.		71		4,171
Heritage Financial Corp./WA		75		2,629
Home BancShares Inc./AR		318		7,374
Hope Bancorp Inc.		282		4,732
Huntington Bancshares Inc./OH		1,901		29,351
IBERIABANK Corp.		112		9,307
Independent Bank Corp./Rockland MA		58		5,127
Independent Bank Group Inc.		43		2,885


Security	Shares		Value

Banks (continued)
International Bancshares Corp.		134	$	5,956
JPMorgan Chase &Co.		2,018		231,969
KeyCorp .		2,018		42,116
Lakeland Bancorp. Inc.		132		2,561
Lakeland Financial Corp.		67		3,249
LegacyTexas Financial Group Inc.		91		3,989
M&T Bank Corp.		119		20,629
MB Financial Inc.		162		7,849
Morgan Stanley		2,184		110,423
National Bank Holdings Corp., Class A		71		2,810
NBT Bancorp. Inc.		113		4,547
Northern Trust Corp.		407		44,453
Old National Bancorp./IN		329		6,399
PacWest Bancorp.		229		11,500
Park National Corp.		33		3,614
Pinnacle Financial Partners Inc.		147		9,188
Popular Inc.		194		9,628
Prosperity Bancshares Inc.		143		10,031
Regions Financial Corp.		2,153		40,067
Renasant Corp.		114		5,094
S&T Bancorp. Inc.		84		3,760
Sandy Spring Bancorp. Inc.		78		3,051
Seacoast Banking Corp. of Florida^(a)		99		2,902
ServisFirst Bancshares Inc.		94		3,972
Simmons First National Corp., Class A		177		5,275
South State Corp.		82		6,863
Southside Bancshares Inc.		85		2,915
State Bank Financial Corp.		96		3,019
State Street Corp.		643		56,783
SunTrust Banks Inc.		894		64,431
SVB Financial Group^(a)		95		29,249
Synovus Financial Corp.		236		11,663
TCF Financial Corp.		260		6,529
Texas Capital Bancshares Inc.^(a)		54		4,903
Tompkins Financial Corp.		38		3,256
U.S. Bancorp.		3,007		159,401
UMB Financial Corp.		94		6,758
Umpqua Holdings Corp.		398		8,477
Union Bankshares Corp.		140		5,671
United Community Banks Inc./GA		128		3,844
Valley National Bancorp.		594		6,920
Webster Financial Corp.		186		12,003
Wells Fargo &Co.		3,849		220,509
WesBanco Inc.		103		5,034
Westamerica Bancorp.		61		3,661
Western Alliance Bancorp.^(a)		152		8,621
Wintrust Financial Corp.		116		10,177
Zions BanCorp.		385		19,905

				2,289,067
Commercial Services — 4.4%
Automatic Data Processing Inc.		246		33,208
CoreLogic Inc./U.S.^(a)		64		3,117
Equifax Inc.		78		9,789
Euronet Worldwide Inc.^(a)		25		2,299
FleetCor Technologies Inc.^(a)		42		9,114
Global Payments Inc.		100		11,257
Green Dot Corp., Class A^(a)		57		4,521
H&R Block Inc.		95		2,390
HealthEquity Inc.^(a)		37		2,793
Insperity Inc.		29		2,758


Security	Shares		Value

Commercial Services (continued)
MarketAxess Holdings Inc.		33	$	6,394
Moody’s Corp.		161		27,550
PayPal Holdings Inc.^(a)		41		3,368
S&P Global Inc.		175		35,077
Service Corp. International/U.S.		111		4,368
Total System Services Inc.		164		15,013
Verisk Analytics Inc.^(a)		127		14,049
Western Union Co. (The)		326		6,572
WEX Inc.^(a)		37		7,023
Worldpay Inc., Class A^(a)		197		16,191

				216,851
Diversified Financial Services — 15.6%
Affiliated Managers Group Inc.		61		9,761
Alliance Data Systems Corp.		33		7,421
Ally Financial Inc.		740		19,802
American Express Co.		1,012		100,714
Ameriprise Financial Inc.		210		30,591
Artisan Partners Asset Management Inc., Class A		70		2,411
BGC Partners Inc., Class A		217		2,331
Cboe Global Markets Inc.		101		9,810
Charles Schwab Corp. (The)		1,876		95,789
CME Group Inc.		236		37,552
Credit Acceptance Corp.^(a)		23		8,823
Discover Financial Services		480		34,277
E*TRADE Financial Corp.^(a)		435		26,017
Eaton Vance Corp., NVS		167		8,873
Evercore Inc., Class A		38		4,294
Franklin Resources Inc.		455		15,616
Hilltop Holdings Inc.		160		3,328
Interactive Brokers Group Inc., Class A		71		4,250
Intercontinental Exchange Inc.		498		36,807
Jefferies Financial Group Inc.		355		8,609
Legg Mason Inc.		140		4,778
LendingTree Inc.^(a)		5		1,194
LPL Financial Holdings Inc.		116		7,690
Mastercard Inc., Class A		461		91,278
Moelis & Co., Class A		41		2,608
Nasdaq Inc.		105		9,597
Navient Corp.		271		3,580
OneMain Holdings Inc.^(a)		116		3,857
Raymond James Financial Inc.		231		21,157
Santander Consumer USA Holdings Inc.		147		2,828
SEI Investments Co.		153		9,171
SLM Corp.^(a)		711		8,027
Stifel Financial Corp.		123		6,781
Synchrony Financial		969		28,043
T Rowe Price Group Inc.		323		38,463
TD Ameritrade Holding Corp.		303		17,316
Visa Inc., Class A		304		41,569
Waddell & Reed Financial Inc., Class A		137		2,837

				767,850
Electric — 0.1%
Hawaiian Electric Industries Inc.		139		4,889


Forest Products & Paper — 0.1%
International Paper Co.		102		5,480


Health Care - Services — 3.4%
Aetna Inc.		193		36,359
Anthem Inc.		138		34,914


Security	Shares		Value

Health Care - Services (continued)
Cigna Corp.		250	$	44,855
Molina Healthcare Inc.^(a)		33		3,435
UnitedHealth Group Inc.		180		45,580
WellCare Health Plans Inc.^(a)		8		2,139

				167,282
Holding Companies - Diversified — 0.1%
Spectrum Brands Holdings Inc.^(a)		23		2,009


Insurance — 21.2%
Aflac Inc.		1,363		63,434
Allstate Corp. (The)		587		55,835
American Financial Group Inc./OH		139		15,664
American International Group Inc.		1,709		94,354
American National Insurance Co.		22		2,838
AmTrust Financial Services Inc.		201		2,911
Arthur J Gallagher &Co.		250		17,838
Assurant Inc.		74		8,162
Berkshire Hathaway Inc., Class B^(a)		625		123,669
Brighthouse Financial Inc.^(a)		154		6,688
Brown & Brown Inc.		331		9,685
Cincinnati Financial Corp.		297		22,462
CNA Financial Corp.		66		3,088
Employers Holdings Inc.		56		2,601
Erie Indemnity Co., Class A, NVS		33		4,100
Fidelity National Financial Inc.		344		13,932
Genworth Financial Inc., Class A^(a)		837		3,850
Hanover Insurance Group Inc. (The)		81		10,159
Hartford Financial Services Group Inc. (The)		674		35,520
Horace Mann Educators Corp.		85		3,715
Kemper Corp.		83		6,623
Lincoln National Corp.		393		26,763
Loews Corp.		240		12,187
Markel Corp.^(a)		19		22,230
Marsh & McLennan Companies Inc.		664		55,351
Mercury General Corp.		60		3,086
MetLife Inc.		1,487		68,015
MGIC Investment Corp.^(a)		653		8,149
National General Holdings Corp.		118		3,254
NMI Holdings Inc., Class A^(a)		119		2,487
Principal Financial Group Inc.		530		30,782
ProAssurance Corp.		105		4,337
Progressive Corp. (The)		1,039		62,350
Prudential Financial Inc.		778		78,508
Radian Group Inc.		374		7,162
RLI Corp.		90		6,728
Safety Insurance Group Inc.		33		3,023
Selective Insurance Group Inc.		112		6,698
Torchmark Corp.		220		19,375
Travelers Companies Inc. (The)		487		63,378
Universal Insurance Holdings Inc.		64		2,842
Unum Group		424		16,846
Voya Financial Inc.		307		15,510
WR Berkley Corp.		189		14,328

				1,040,517
Leisure Time — 0.1%
Harley-Davidson Inc.		81		3,474


Machinery — 0.8%
Caterpillar Inc.		265		38,107


Security	Shares		Value

Manufacturing — 2.1%
General Electric Co.		7,582	$	103,343


Media — 0.1%
FactSet Research Systems Inc.		16		3,222


Pharmaceuticals — 0.1%
Express Scripts Holding Co.^(a)		80		6,357


Real Estate — 0.0%
Realogy Holdings Corp.		87		1,903


Real Estate Investment Trusts — 0.9%
AGNC Investment Corp.		213		4,147
Annaly Capital Management Inc.		930		9,970
Colony Capital Inc.		415		2,556
MFA Financial Inc.		382		3,075
New Residential Investment Corp.		268		4,794
Two Harbors Investment Corp.		150		2,325
Weyerhaeuser Co.		492		16,817

				43,684

Retail — 0.1%
FirstCash Inc.		30		2,436
Nu Skin Enterprises Inc., Class A		40		2,914

				5,350

Savings & Loans — 1.7%
Beneficial Bancorp. Inc.		159		2,584
Berkshire Hills Bancorp. Inc.		75		3,045
BofI Holding Inc.^(a)		95		3,707
Brookline Bancorp. Inc.		175		3,185
Capitol Federal Financial Inc.		292		3,816
Investors Bancorp. Inc.		501		6,272
Meridian Bancorp. Inc.		113		2,068
Meta Financial Group Inc.		19		1,700
New York Community Bancorp. Inc.		937		10,091
Northwest Bancshares Inc.		224		4,036
OceanFirst Financial Corp.		97		2,829
Pacific Premier Bancorp. Inc.^(a)		95		3,515


Security	Shares		Value

Savings & Loans (continued)
People’s United Financial Inc.		759	$	13,837
Provident Financial Services Inc.		140		3,576
Sterling Bancorp./DE		450		9,990
Washington Federal Inc.		174		5,838
WSFS Financial Corp.		71		4,026

				84,115

Software — 1.6%
Black Knight Inc.^(a)		48		2,479
Broadridge Financial Solutions Inc.		90		10,168
Fidelity National Information Services Inc.		285		29,392
First Data Corp., Class A^(a)		285		6,629
Fiserv Inc.^(a)		191		14,417
Guidewire Software Inc.^(a)		40		3,448
MSCI Inc.		47		7,811
SS&C Technologies Holdings Inc.		91		4,830

				79,174

Total Common Stocks — 98.9%
(Cost: $4,866,979)				4,862,674


Short-Term Investments

Money Market Funds — 0.8%
BlackRock Cash Funds: Treasury, SL Agency Shares, 1.83%^(b)(c)		39,373		39,373


Total Short-Term Investments — 0.8%
(Cost: $39,373)				39,373


Total Investments in Securities — 99.7%
(Cost: $4,906,352)				4,902,047

Other Assets, Less Liabilities — 0.3%				16,906


Net Assets — 100.0%			$	4,918,953

^(a)	Non-income producing security.

^(b)	Affiliate of the Fund.

^(c)	Annualized 7-day yield as of period-end.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Security	Shares		Value

Common Stocks

Aerospace & Defense — 1.0%
Boeing Co. (The)		20	$	7,126
Lockheed Martin Corp.		40		13,044
Northrop Grumman Corp.		76		22,837
Raytheon Co.		52		10,298

				53,305
Biotechnology — 3.5%
Bio-Rad Laboratories Inc., Class A^(a)		48		14,719
Exact Sciences Corp.^(a)		352		20,574
Illumina Inc.^(a)		440		142,719
Myriad Genetics Inc.^(a)		192		8,400
NeoGenomics Inc.^(a)		240		3,360

				189,772
Commercial Services — 1.2%
Adtalem Global Education Inc.^(a)		116		6,328
AMN Healthcare Services Inc.^(a)		132		7,986
ASGN Inc.^(a)		32		2,890
Bright Horizons Family Solutions Inc.^(a)		64		6,847
Career Education Corp.^(a)		116		2,134
Graham Holdings Co., Class B		8		4,472
Grand Canyon Education Inc.^(a)		76		8,856
Healthcare Services Group Inc.		176		7,086
HealthEquity Inc.^(a)		56		4,228
HMS Holdings Corp.^(a)		260		6,222
Insperity Inc.		40		3,804
Strategic Education Inc.		20		2,357

				63,210
Computers — 0.4%
Conduent Inc.^(a)		240		4,310
Leidos Holdings Inc.		136		9,305
MAXIMUS Inc.		140		9,074

				22,689
Diversified Financial Services — 0.1%
WageWorks Inc.^(a)		52		2,746


Electrical Components & Equipment — 0.0%
Novanta Inc.^(a)		44		2,743


Electronics — 1.4%
Accelerate Diagnostics Inc.^(a)		96		2,107
Agilent Technologies Inc.		572		37,775
OSI Systems Inc.^(a)		36		2,871
PerkinElmer Inc.		208		16,470
Waters Corp.^(a)		96		18,938

				78,161
Engineering & Construction — 0.1%
AECOM^(a)		84		2,819


Environmental Control — 0.1%
Stericycle Inc.^(a)		96		6,707


Health Care - Products — 36.9%
Abaxis Inc.		52		4,316
Abbott Laboratories		4,256		278,938
ABIOMED Inc.^(a)		124		43,962
Align Technology Inc.^(a)		108		38,518
AngioDynamics Inc.^(a)		96		2,029
AtriCure Inc.^(a)		96		2,750
Atrion Corp.		4		2,752


Security	Shares		Value

Health Care - Products (continued)
Avanos Medical Inc.^(a)		80	$	4,416
AxoGen Inc.^(a)		44		1,977
Baxter International Inc.		752		54,482
Becton Dickinson and Co.		688		172,255
Bio-Techne Corp.		56		8,996
BioTelemetry Inc.^(a)		92		4,830
Boston Scientific Corp.^(a)		3,816		128,256
Bruker Corp.		152		4,925
Cantel Medical Corp.		48		4,450
Cardiovascular Systems Inc.^(a)		84		3,186
Cooper Companies Inc. (The)		140		36,470
Cutera Inc.^(a)		28		1,120
Danaher Corp.		1,388		142,381
DENTSPLY SIRONA Inc.		372		17,897
Edwards Lifesciences Corp.^(a)		656		93,447
Foundation Medicine Inc.^(a)		32		4,384
Genomic Health Inc.^(a)		48		2,577
Globus Medical Inc., Class A^(a)		168		8,649
Haemonetics Corp.^(a)		96		9,373
Henry Schein Inc.^(a)		400		31,764
Hill-Rom Holdings Inc.		160		15,072
Hologic Inc.^(a)		656		28,149
ICU Medical Inc.^(a)		40		11,472
IDEXX Laboratories Inc.^(a)		164		40,169
Inogen Inc.^(a)		52		10,361
Insulet Corp.^(a)		132		10,977
Integer Holdings Corp.^(a)		60		4,287
Integra LifeSciences Holdings Corp.^(a)		168		10,472
Intersect ENT Inc.^(a)		44		1,423
Intuitive Surgical Inc.^(a)		380		193,112
iRhythm Technologies Inc.^(a)		56		4,231
K2M Group Holdings Inc.^(a)		104		2,119
LeMaitre Vascular Inc.		44		1,584
Luminex Corp.		92		3,115
Masimo Corp.^(a)		148		14,714
Merit Medical Systems Inc.^(a)		136		7,385
Natus Medical Inc.^(a)		84		3,066
Nevro Corp.^(a)		64		3,601
NuVasive Inc.^(a)		144		8,359
NxStage Medical Inc.^(a)		172		4,828
OPKO Health Inc.^(a)		628		3,529
OraSure Technologies Inc.^(a)		156		2,619
Patterson Companies Inc.		200		4,904
Penumbra Inc.^(a)		84		11,949
Quidel Corp.^(a)		80		5,429
ResMed Inc.		408		43,158
Stryker Corp.		892		145,619
Teleflex Inc.		116		31,634
Thermo Fisher Scientific Inc.		864		202,634
Varex Imaging Corp.^(a)		68		2,600
Varian Medical Systems Inc.^(a)		184		21,243
Zimmer Biomet Holdings Inc.		524		65,773

				2,028,687
Health Care - Services — 39.0%
Acadia Healthcare Co. Inc.^(a)		256		10,107
Aetna Inc.		980		184,622
Amedisys Inc.^(a)		120		11,236
Anthem Inc.		788		199,364
Brookdale Senior Living Inc.^(a)		476		4,565
Centene Corp.^(a)		588		76,634


Security	Shares		Value

Health Care - Services (continued)
Charles River Laboratories International Inc.^(a)		36	$	4,475
Chemed Corp.		40		12,641
Cigna Corp.		536		96,169
Community Health Systems Inc.^(a)		388		1,296
DaVita Inc.^(a)		608		42,730
Encompass Health Corp.		388		29,344
Ensign Group Inc. (The)		184		6,637
Envision Healthcare Corp.^(a)		504		22,307
HCA Healthcare Inc.		1,180		146,591
Humana Inc.		500		157,090
IQVIA Holdings Inc.^(a)		240		29,266
Laboratory Corp. of America Holdings^(a)		328		57,512
LHC Group Inc.^(a)		115		9,899
LifePoint Health Inc.^(a)		148		9,590
Magellan Health Inc.^(a)		76		5,529
MEDNAX Inc.^(a)		372		15,918
Molina Healthcare Inc.^(a)		84		8,744
National HealthCare Corp.		32		2,307
Providence Service Corp. (The)^(a)		40		2,803
Quest Diagnostics Inc.		452		48,689
Select Medical Holdings Corp.^(a)		448		9,318
Syneos Health Inc.^(a)		48		2,365
Teladoc Inc.^(a)		128		7,661
Tenet Healthcare Corp.^(a)		356		13,396
Tivity Health Inc.^(a)		148		4,988
U.S. Physical Therapy Inc.		48		5,028
UnitedHealth Group Inc.		3,264		826,510
Universal Health Services Inc., Class B		320		39,072
WellCare Health Plans Inc.^(a)		152		40,648

				2,145,051

Internet — 0.0%
HealthStream Inc.		68		1,909


Pharmaceuticals — 9.1%
Akorn Inc.^(a)		100		1,852
AmerisourceBergen Corp.		412		33,714
Cardinal Health Inc.		840		41,958
CVS Health Corp.		3,168		205,476
DexCom Inc.^(a)		180		17,123
Diplomat Pharmacy Inc.^(a)		184		3,824
Express Scripts Holding Co.^(a)		1,520		120,779
McKesson Corp.		496		62,298
Owens & Minor Inc.		136		2,566
PRA Health Sciences Inc.^(a)		56		5,888
Premier Inc., Class A^(a)		188		7,031

				502,509

Real Estate Investment Trusts — 2.7%
CoreCivic Inc.		184		4,718
GEO Group Inc. (The)		208		5,383
HCP Inc.		632		16,369


Security	Shares		Value

Real Estate Investment Trusts (continued)
LTC Properties Inc.		60	$	2,530
Medical Properties Trust Inc.		924		13,315
National Health Investors Inc.		80		5,987
Omega Healthcare Investors Inc.		268		7,957
Physicians Realty Trust		328		5,169
Sabra Health Care REIT Inc.		320		6,915
Ventas Inc.		568		32,024
Welltower Inc.		800		50,080

				150,447
Retail — 1.8%
Rite Aid Corp.^(a)		2,212		4,446
Walgreens Boots Alliance Inc.		1,400		94,668

				99,114
Software — 1.8%
2U Inc.^(a)(b)		56		4,237
Allscripts Healthcare Solutions Inc.^(a)		536		6,561
athenahealth Inc.^(a)		76		11,454
Cerner Corp.^(a)		932		57,858
Cotiviti Holdings Inc.^(a)		108		4,821
Evolent Health Inc., Class A^(a)		196		3,959
Omnicell Inc.^(a)		84		4,998
Tabula Rasa HealthCare Inc.^(a)		40		2,330

				96,218


Total Common Stocks — 99.1%
(Cost: $4,916,167)				5,446,087


Short-Term Investments

Money Market Funds — 0.9%
BlackRock Cash Funds: Institutional, SL Agency Shares, 2.14%^(c)(d)(e)		4,308		4,310
BlackRock Cash Funds: Treasury, SL Agency Shares, 1.83%^(c)(d)		46,420		46,420

				50,730


Total Short-Term Investments — 0.9%
(Cost: $50,729)				50,730


Total Investments in Securities — 100.0%
(Cost: $4,966,896)				5,496,817

Other Assets, Less Liabilities — (0.0)%				(1,443	)


Net Assets — 100.0%			$	5,495,374

^(a)	Non-income producing security.

^(b)	All or a portion of this security is on loan.

^(c)	Affiliate of the Fund.

^(d)	Annualized 7-day yield as of period-end.

^(e)	All or a portion of this security was purchased with cash collateral received from loaned securities.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Security	Shares		Value

Common Stocks

Biotechnology — 43.8%
Abeona Therapeutics Inc.^(a)		136	$	1,965
ACADIA Pharmaceuticals Inc.^(a)		412		6,217
Acceleron Pharma Inc.^(a)		188		8,189
Achillion Pharmaceuticals Inc.^(a)		624		1,610
Acorda Therapeutics Inc.^(a)		204		5,090
Aduro Biotech Inc.^(a)		184		1,076
Agenus Inc.^(a)		348		637
Alder Biopharmaceuticals Inc.^(a)		312		5,912
Alexion Pharmaceuticals Inc.^(a)		917		121,924
Alnylam Pharmaceuticals Inc.^(a)		496		47,120
AMAG Pharmaceuticals Inc.^(a)		128		2,822
Amgen Inc.		1,371		269,470
Amicus Therapeutics Inc.^(a)		876		12,746
AnaptysBio Inc.^(a)		68		5,326
ANI Pharmaceuticals Inc.^(a)		28		1,875
Arena Pharmaceuticals Inc.^(a)		256		9,879
ArQule Inc.^(a)		498		2,480
Arrowhead Pharmaceuticals Inc.^(a)		360		5,245
Assembly Biosciences Inc.^(a)		88		3,892
Atara Biotherapeutics Inc.^(a)		128		4,806
Audentes Therapeutics Inc.^(a)		128		4,819
AVEO Pharmaceuticals Inc.^(a)		536		1,142
BioCryst Pharmaceuticals Inc.^(a)		428		2,525
Biogen Inc.^(a)		752		251,446
BioMarin Pharmaceutical Inc.^(a)		869		87,387
Bio-Rad Laboratories Inc., Class A^(a)		8		2,453
Bluebird Bio Inc.^(a)		284		43,992
Blueprint Medicines Corp.^(a)		184		10,955
Cambrex Corp.^(a)		48		3,000
Cara Therapeutics Inc.^(a)		144		2,582
Celgene Corp.^(a)		2,745		247,297
Celldex Therapeutics Inc.^(a)		668		311
ChemoCentryx Inc.^(a)		132		1,526
Cymabay Therapeutics Inc.^(a)		319		3,570
CytomX Therapeutics Inc.^(a)		156		4,109
Deciphera Pharmaceuticals Inc.^(a)		84		2,890
Denali Therapeutics Inc.^(a)		344		4,331
Dicerna Pharmaceuticals Inc.^(a)		192		2,419
Dynavax Technologies Corp.^(a)		256		3,456
Editas Medicine Inc.^(a)		192		5,710
Emergent BioSolutions Inc.^(a)		128		6,957
Epizyme Inc.^(a)		240		3,096
Esperion Therapeutics Inc.^(a)		124		5,573
Exact Sciences Corp.^(a)		184		10,755
Exelixis Inc.^(a)		1,288		26,662
Fate Therapeutics Inc.^(a)		220		1,965
FibroGen Inc.^(a)		312		19,687
Five Prime Therapeutics Inc.^(a)		180		2,682
Geron Corp.^(a)(b)		492		1,766
Gilead Sciences Inc.		3,230		251,391
GlycoMimetics Inc.^(a)		185		2,718
Halozyme Therapeutics Inc.^(a)		480		8,688
ImmunoGen Inc.^(a)		758		7,049
Immunomedics Inc.^(a)		804		19,240
Incyte Corp.^(a)		356		23,688
Innoviva Inc.^(a)		236		3,339
Insmed Inc.^(a)		360		8,953
Intellia Therapeutics Inc.^(a)		136		3,620


Security	Shares		Value

Biotechnology (continued)
Intercept Pharmaceuticals Inc.^(a)		88	$	8,020
Intrexon Corp.^(a)(b)		176		2,580
Ionis Pharmaceuticals Inc.^(a)(b)		580		25,334
Iovance Biotherapeutics Inc.^(a)		396		5,623
Karyopharm Therapeutics Inc.^(a)		224		3,983
Lexicon Pharmaceuticals Inc.^(a)		212		2,540
Ligand Pharmaceuticals Inc.^(a)		96		20,960
Loxo Oncology Inc.^(a)		137		22,960
MacroGenics Inc.^(a)		160		3,304
Medicines Co. (The)^(a)		312		12,396
Myriad Genetics Inc.^(a)		140		6,125
Novavax Inc.^(a)		1,288		1,636
Omeros Corp.^(a)		188		3,959
Pieris Pharmaceuticals Inc.^(a)		256		1,406
PTC Therapeutics Inc.^(a)		202		7,690
Puma Biotechnology Inc.^(a)		156		7,511
Radius Health Inc.^(a)		200		4,800
Regeneron Pharmaceuticals Inc.^(a)		379		139,476
REGENXBIO Inc.^(a)		136		9,561
Retrophin Inc.^(a)		188		5,196
Rigel Pharmaceuticals Inc.^(a)		716		2,019
Sage Therapeutics Inc.^(a)		247		35,647
Sangamo Therapeutics Inc.^(a)		396		5,405
Seattle Genetics Inc.^(a)		516		36,326
Solid Biosciences Inc.^(a)		65		2,613
Spark Therapeutics Inc.^(a)		152		11,662
Spectrum Pharmaceuticals Inc.^(a)		468		9,964
Stemline Therapeutics Inc.^(a)		148		2,279
Ultragenyx Pharmaceutical Inc.^(a)		224		17,721
United Therapeutics Corp.^(a)		188		23,107
Verastem Inc.^(a)		403		3,103
Vertex Pharmaceuticals Inc.^(a)		1,266		221,613
Viking Therapeutics Inc.^(a)		258		2,632
ZIOPHARM Oncology Inc.^(a)(b)		608		1,575

				2,282,756

Electrical Components & Equipment — 0.1%
Universal Display Corp.		56		5,393


Health Care - Products — 6.9%
Abaxis Inc.		24		1,992
Abbott Laboratories		1,984		130,031
ABIOMED Inc.^(a)		60		21,272
AxoGen Inc.^(a)		56		2,516
Baxter International Inc.		604		43,760
Bio-Techne Corp.		44		7,068
Cooper Companies Inc. (The)		68		17,714
Foundation Medicine Inc.^(a)		32		4,384
Glaukos Corp.^(a)		104		4,327
Globus Medical Inc., Class A^(a)		84		4,324
Haemonetics Corp.^(a)		52		5,077
Hologic Inc.^(a)		144		6,179
ICU Medical Inc.^(a)		20		5,736
IDEXX Laboratories Inc.^(a)		92		22,534
Insulet Corp.^(a)		84		6,986
Integra LifeSciences Holdings Corp.^(a)		68		4,238
Intersect ENT Inc.^(a)		72		2,329
Intuitive Surgical Inc.^(a)		45		22,869
Lantheus Holdings Inc.^(a)		112		1,618
Merit Medical Systems Inc.^(a)		52		2,824
Nevro Corp.^(a)		56		3,151


Security	Shares		Value

Health Care - Products (continued)
NxStage Medical Inc.^(a)		68	$	1,909
OPKO Health Inc.^(a)		916		5,148
Penumbra Inc.^(a)		52		7,397
Quidel Corp.^(a)		40		2,714
Repligen Corp.^(a)		88		4,253
ResMed Inc.		180		19,040

				361,390
Health Care - Services — 0.9%
Catalent Inc.^(a)		208		8,674
Charles River Laboratories International Inc.^(a)		72		8,950
IQVIA Holdings Inc.^(a)		208		25,363
Syneos Health Inc.^(a)		112		5,519

				48,506
Pharmaceuticals — 47.4%
AbbVie Inc.		2,671		246,346
Achaogen Inc.^(a)(b)		152		1,082
Aclaris Therapeutics Inc.^(a)		136		2,331
Adamas Pharmaceuticals Inc.^(a)		92		2,188
Aerie Pharmaceuticals Inc.^(a)		180		12,159
Agios Pharmaceuticals Inc.^(a)		228		19,702
Aimmune Therapeutics Inc.^(a)		192		5,553
Akcea Therapeutics Inc.^(a)(b)		52		1,644
Akebia Therapeutics Inc.^(a)		200		2,060
Akorn Inc.^(a)		208		3,852
AmerisourceBergen Corp.		56		4,583
Amneal Pharmaceuticals Inc.^(a)		1,293		24,787
Amphastar Pharmaceuticals Inc.^(a)		132		2,303
Anika Therapeutics Inc.^(a)		40		1,601
Apellis Pharmaceuticals Inc.^(a)		135		2,484
Array BioPharma Inc.^(a)		944		14,528
Athenex Inc.^(a)		140		2,698
Bausch Health Companies Inc.^(a)		888		19,305
Bristol-Myers Squibb Co.		3,832		225,130
Clovis Oncology Inc.^(a)		232		10,241
Coherus Biosciences Inc.^(a)		196		3,734
Collegium Pharmaceutical Inc.^(a)		108		2,081
Concert Pharmaceuticals Inc.^(a)		96		1,535
Corbus Pharmaceuticals Holdings Inc.^(a)		224		1,131
Corcept Therapeutics Inc.^(a)		440		5,777
Cytokinetics Inc.^(a)		216		1,588
Dermira Inc.^(a)		276		2,688
DexCom Inc.^(a)		148		14,079
Dova Pharmaceuticals Inc.^(a)		64		1,381
Eagle Pharmaceuticals Inc./DE^(a)		56		4,438
Eli Lilly & Co.		2,782		274,889
Enanta Pharmaceuticals Inc.^(a)		68		6,631
Flexion Therapeutics Inc.^(a)(b)		156		3,722
G1 Therapeutics Inc.^(a)		88		4,519
Global Blood Therapeutics Inc.^(a)		220		9,196
Heron Therapeutics Inc.^(a)		328		12,284
Intra-Cellular Therapies Inc.^(a)		208		4,175
Ironwood Pharmaceuticals Inc.^(a)		600		11,568
Johnson & Johnson		3,740		495,625
Jounce Therapeutics Inc.^(a)		72		508
Keryx Biopharmaceuticals Inc.^(a)		492		2,086
Kura Oncology Inc.^(a)		148		3,004
La Jolla Pharmaceutical Co.^(a)(b)		92		3,042
Lannett Co. Inc.^(a)		116		1,479
Madrigal Pharmaceuticals Inc.^(a)		16		4,113


Security	Shares		Value

Pharmaceuticals (continued)
MediciNova Inc.^(a)		164	$	1,551
Merck & Co. Inc.		4,656		306,691
Mirati Therapeutics Inc.^(a)		155		9,517
Momenta Pharmaceuticals Inc.^(a)		324		9,590
MyoKardia Inc.^(a)		140		8,036
Nektar Therapeutics^(a)		799		42,027
Neurocrine Biosciences Inc.^(a)		468		47,029
Pacira Pharmaceuticals Inc./DE^(a)		152		6,110
Paratek Pharmaceuticals Inc.^(a)		124		1,252
Pfizer Inc.		8,828		352,502
Portola Pharmaceuticals Inc.^(a)		356		12,745
PRA Health Sciences Inc.^(a)		84		8,832
Prestige Brands Holdings Inc.^(a)		64		2,287
Progenics Pharmaceuticals Inc.^(a)		308		2,459
Reata Pharmaceuticals Inc. Series A^(a)		72		5,048
Revance Therapeutics Inc.^(a)		144		4,140
Rhythm Pharmaceuticals Inc.^(a)		80		2,483
Rocket Pharmaceuticals Inc.^(a)		105		2,154
Sarepta Therapeutics Inc.^(a)(b)		329		38,243
Sorrento Therapeutics Inc.^(a)(b)		276		1,546
Supernus Pharmaceuticals Inc.^(a)		220		11,649
Synergy Pharmaceuticals Inc.^(a)(b)		1,136		1,931
TESARO Inc.^(a)		184		6,409
TG Therapeutics Inc.^(a)		236		2,773
TherapeuticsMD Inc.^(a)(b)		640		3,341
Vanda Pharmaceuticals Inc.^(a)		224		4,670
Voyager Therapeutics Inc.^(a)(b)		128		2,414
Xencor Inc.^(a)		240		8,933
Zoetis Inc.		816		70,568
Zogenix Inc.^(a)		152		8,626

				2,465,406
Telecommunications — 0.1%
InterDigital Inc./PA		36		2,968


Total Common Stocks — 99.2% (Cost: $4,910,224)				5,166,419


Short-Term Investments

Money Market Funds — 2.6%
BlackRock Cash Funds: Institutional, SL Agency Shares,
2.14%^(c)(d)(e)		80,074		80,097
BlackRock Cash Funds: Treasury, SL Agency Shares, 1.83%^(c)(d)		53,493		53,493

				133,590


Total Short-Term Investments — 2.6% (Cost: $133,582)				133,590


Total Investments in Securities — 101.8% (Cost: $5,043,806)				5,300,009

Other Assets, Less Liabilities — (1.8)%				(94,468	)


Net Assets — 100.0%			$	5,205,541

^(a)	Non-income producing security.

^(b)	All or a portion of this security is on loan.

^(c)	Affiliate of the Fund.

^(d)	Annualized 7-day yield as of period-end.

^(e)	All or a portion of this security was purchased with cash collateral received from loaned securities.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Affiliated Issuer	Shares Held at 03/21/18	^(a)	Net Activity	Shares Held at 07/31/18		Value at 07/31/18		Income			Net Realized Gain (Loss)	^(b)		Change in Unrealized Appreciation (Depreciation)
BlackRock Cash Funds: Institutional, SL Agency Shares	—		80,074	80,074	$	80,097	$	172	^(c)	$	4		$	8
BlackRock Cash Funds: Treasury, SL Agency Shares	—		53,493	53,493		53,493		276			—			—

					$	133,590	$	448		$	4		$	8


	Level 1		Level 2		Level 3		Total
Investments
Assets
Common Stocks	$	5,162,035	$	4,384	$	—	$	5,166,419
Money Market Funds		133,590		—		—		133,590

	$	5,295,625	$	4,384	$	—	$	5,300,009


Security	Shares		Value

Common Stocks

Commercial Services — 0.6%
Graham Holdings Co., Class B		48	$	26,832
Viad Corp.		64		3,673

				30,505
Entertainment — 7.3%
AMC Entertainment Holdings Inc., Class A		440		7,172
Cinemark Holdings Inc.		1,244		44,684
Dolby Laboratories Inc., Class A		564		36,350
IMAX Corp.^(a)(b)		768		16,973
Lions Gate Entertainment Corp., Class A		1,276		30,433
Lions Gate Entertainment Corp., Class B, NVS		2,424		55,437
Live Nation Entertainment Inc.^(a)(b)		1,008		49,674
Madison Square Garden Co. (The), Class A^(a)		192		59,938
National CineMedia Inc.		964		7,963
Reading International Inc., Class A, NVS^(a)		180		2,844
Scientific Games Corp./DE, Class A^(a)		324		15,568
SeaWorld Entertainment Inc.^(a)		476		10,139
Six Flags Entertainment Corp.		748		48,583
Speedway Motorsports Inc.		148		2,612

				388,370
Internet — 7.5%
IAC/InterActiveCorp.^(a)		464		68,324
Netflix Inc.^(a)		780		263,211
New Media Investment Group Inc.		472		8,491
Pandora Media Inc.^(a)		2,064		13,911
Snap Inc., Class A, NVS^(a)		2,816		35,200
Twitter Inc.^(a)		188		5,992

				395,129
Leisure Time — 0.1%
Liberty TripAdvisor Holdings Inc., Class A^(a)(b)		212		3,530


Lodging — 0.1%
Marcus Corp. (The)		120		4,626


Media — 63.3%
Altice USA Inc., Class A		988		16,924
AMC Networks Inc., Class A^(a)(b)		864		52,091
Cable One Inc.		48		34,745
CBS Corp., Class B, NVS		4,932		259,768
Charter Communications Inc., Class A^(a)		756		230,263
Comcast Corp., Class A		8,228		294,398
Daily Journal Corp.^(a)(b)		8		1,878
Discovery Inc., Class A^(a)		2,752		73,148
Discovery Inc., Class C, NVS^(a)		4,864		119,411
DISH Network Corp., Class A^(a)(b)		2,532		79,910
Entercom Communications Corp., Class A		2,648		19,992
EW Scripps Co. (The), Class A, NVS		1,376		18,026
Gannett Co. Inc.		996		10,528
Gray Television Inc.^(a)		1,888		29,170
Hemisphere Media Group Inc.^(a)(b)		412		4,944
Houghton Mifflin Harcourt Co.^(a)		516		3,277
Liberty Broadband Corp., Class A^(a)		288		22,850
Liberty Broadband Corp., Class C, NVS^(a)		1,156		91,867
Liberty Media Corp.-Liberty SiriusXM, Class A^(a)		1,284		60,528
Liberty Media Corp.-Liberty SiriusXM, Class C, NVS^(a)		2,576		121,664
Meredith Corp.		760		40,394
MSG Networks Inc., Class A^(a)		1,052		24,775
New York Times Co. (The), Class A		1,620		40,176
News Corp., Class A, NVS		5,396		81,318


Security	Shares		Value

Media (continued)
News Corp., Class B		1,728	$	26,438
Nexstar Media Group Inc., Class A		1,000		74,450
Saga Communications Inc., Class A		108		4,088
Scholastic Corp., NVS		216		9,020
Sinclair Broadcast Group Inc., Class A		1,720		44,376
Sirius XM Holdings Inc.^(b)		14,272		100,189
TEGNA Inc.		4,292		47,341
Tribune Media Co., Class A		1,252		42,380
Twenty-First Century Fox Inc., Class A, NVS		6,748		303,660
Twenty-First Century Fox Inc., Class B		6,856		304,544
Viacom Inc., Class A		220		7,568
Viacom Inc., Class B, NVS		7,664		222,639
Walt Disney Co. (The)		3,148		357,487
World Wrestling Entertainment Inc., Class A^(b)		848		67,085

				3,343,310
Real Estate Investment Trusts — 0.8%
Lamar Advertising Co., Class A		460		33,870
Ryman Hospitality Properties Inc.		84		7,141

				41,011
Software — 11.3%
Activision Blizzard Inc.		3,448		253,152
Electronic Arts Inc.^(a)		1,816		233,810
Glu Mobile Inc.^(a)		804		4,285
Take-Two Interactive Software Inc.^(a)		672		75,950
TiVo Corp.		1,308		15,892
Zynga Inc., Class A^(a)		3,060		11,597

				594,686
Telecommunications — 2.4%
AT&T Inc.		3,718		118,865
Harmonic Inc.^(a)(b)		464		2,134
Shenandoah Telecommunications Co.		124		4,092

				125,091
Toys, Games & Hobbies — 3.2%
Hasbro Inc.		1,312		130,688
Mattel Inc.		2,408		38,215

				168,903


Total Common Stocks — 96.6% (Cost: $4,818,270)				5,095,161


Short-Term Investments

Money Market Funds — 10.6%
BlackRock Cash Funds: Institutional, SL Agency Shares,
2.14%^(c)(d)(e)		381,922		382,037
BlackRock Cash Funds: Treasury, SL Agency Shares,
1.83%^(c)(d)		178,979		178,979

				561,016


Total Short-Term Investments — 10.6% (Cost: $560,978)				561,016


Total Investments in Securities — 107.2% (Cost: $5,379,248)				5,656,177

Other Assets, Less Liabilities — (7.2)%				(379,379	)


Net Assets — 100.0%			$	5,276,798

^(a)	Non-income producing security.

^(b)	All or a portion of this security is on loan.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Affiliated Issuer	Shares Held at 03/21/18	^(a)	Net Activity	Shares Held at 07/31/18		Value at 07/31/18		Income			Net Realized Gain (Loss)	^(b)		Change in Unrealized Appreciation (Depreciation)
BlackRock Cash Funds: Institutional, SL Agency Shares	—		381,922	381,922	$	382,037	$	305	^(c)	$	16		$	38
BlackRock Cash Funds: Treasury, SL Agency Shares	—		178,979	178,979		178,979		564			—			—

					$	561,016	$	869		$	16		$	38


	Level 1		Level 2		Level 3		Total
Investments
Assets
Common Stocks	$	5,095,161	$	—	$	—	$	5,095,161
Money Market Funds		561,016		—		—		561,016

	$	5,656,177	$	—	$	—	$	5,656,177


Security	Shares		Value

Common Stocks

Advertising — 0.2%
Interpublic Group of Companies Inc. (The)		212	$	4,781
Omnicom Group Inc.		116		7,984

				12,765
Aerospace & Defense — 0.2%
Northrop Grumman Corp.		16		4,808
Raytheon Co.		24		4,753

				9,561
Auto Parts & Equiptment — 0.0%
Lear Corp.		12		2,162


Banks — 0.3%
JPMorgan Chase &Co.		156		17,932


Biotechnology — 0.1%
Incyte Corp.^(a)		40		2,662


Commercial Services — 4.3%
Automatic Data Processing Inc.		224		30,238
Booz Allen Hamilton Holding Corp.		60		2,836
CoreLogic Inc./U.S.^(a)		36		1,753
CoStar Group Inc.^(a)		16		6,654
Deluxe Corp.		28		1,650
Equifax Inc.		56		7,028
Euronet Worldwide Inc.^(a)		20		1,839
FleetCor Technologies Inc.^(a)		40		8,680
Gartner Inc.^(a)(b)		64		8,668
Global Payments Inc.		76		8,555
Korn/Ferry International		32		2,111
ManpowerGroup Inc.		28		2,611
MarketAxess Holdings Inc.		16		3,100
Moody’s Corp.		52		8,898
PayPal Holdings Inc.^(a)		676		55,527
Robert Half International Inc.		44		3,334
S&P Global Inc.		96		19,242
Sabre Corp.		124		3,053
Square Inc., Class A^(a)		164		10,603
Total System Services Inc.		68		6,225
TransUnion		96		6,950
Verisk Analytics Inc.^(a)		60		6,637
Western Union Co. (The)		156		3,145
WEX Inc.^(a)		16		3,037
Worldpay Inc., Class A^(a)		152		12,493

				224,867
Computers — 15.8%
Apple Inc.		2,964		564,020
Cognizant Technology Solutions Corp., Class A		400		32,600
Conduent Inc.^(a)		100		1,796
Dell Technologies Inc., Class V^(a)		156		14,433
EPAM Systems Inc.^(a)		32		4,167
Fortinet Inc.^(a)		128		8,052
Hewlett Packard Enterprise Co.		1,272		19,640
HP Inc.		776		17,910
International Business Machines Corp.		832		120,582
Lumentum Holdings Inc.^(a)		24		1,254
NCR Corp.^(a)		64		1,787
NetApp Inc.		240		18,605
NetScout Systems Inc.^(a)		68		1,822
Nutanix Inc., Class A^(a)(b)		88		4,302
Pure Storage Inc., Class A^(a)		88		1,906


Security	Shares		Value

Computers (continued)
Qualys Inc.^(a)		32	$	2,787
Teradata Corp.^(a)		96		3,676
Western Digital Corp.		192		13,469

				832,808
Distribution & Wholesale — 0.0%
KAR Auction Services Inc.		36		2,140


Diversified Financial Services — 5.9%
Alliance Data Systems Corp.		20		4,498
Cboe Global Markets Inc.		40		3,885
CME Group Inc.		120		19,094
Discover Financial Services		32		2,285
Ellie Mae Inc.^(a)(b)		28		2,778
Interactive Brokers Group Inc., Class A		24		1,437
Intercontinental Exchange Inc.		232		17,147
Mastercard Inc., Class A		512		101,376
Nasdaq Inc.		44		4,022
SEI Investments Co.		48		2,877
TD Ameritrade Holding Corp.		84		4,801
Visa Inc., Class A		1,052		143,850

				308,050
Electronics — 0.6%
Agilent Technologies Inc.		80		5,283
Arrow Electronics Inc.^(a)		32		2,427
Avnet Inc.		60		2,631
Coherent Inc.^(a)		8		1,264
Jabil Inc.		60		1,690
Keysight Technologies Inc.^(a)		84		4,872
Mettler-Toledo International Inc.^(a)		4		2,370
National Instruments Corp.		76		3,330
SYNNEX Corp.		16		1,544
Tech Data Corp.^(a)		24		2,002
Trimble Inc.^(a)		104		3,671

				31,084
Health Care - Products — 0.2%
Align Technology Inc.^(a)(b)		28		9,986


Health Care - Services — 0.1%
IQVIA Holdings Inc.^(a)		44		5,365


Insurance — 0.2%
Marsh & McLennan Companies Inc.		108		9,003


Internet — 29.1%
Alphabet Inc., Class A^(a)		232		284,715
Alphabet Inc., Class C,NVS^(a)		236		287,273
Amazon.com Inc.^(a)		232		412,366
Booking Holdings Inc.^(a)		20		40,574
CDW Corp./DE		88		7,400
eBay Inc.^(a)		680		22,746
Expedia Group Inc.		52		6,960
F5 Networks Inc.^(a)		52		8,912
Facebook Inc., Class A^(a)		1,864		321,689
FireEye Inc.^(a)		124		1,926
GoDaddy Inc., Class A^(a)		92		6,773
GrubHub Inc.^(a)		36		4,388
IAC/InterActiveCorp.^(a)		36		5,301
MercadoLibre Inc.		24		8,230
Netflix Inc.^(a)		96		32,395
Okta Inc.^(a)(b)		40		1,986
Palo Alto Networks Inc.^(a)		80		15,861


Security	Shares		Value

Internet (continued)
Proofpoint Inc.^(a)		44	$	5,018
RingCentral Inc., Class A^(a)		44		3,245
Snap Inc., Class A, NVS^(a)(b)		268		3,350
Stamps.com Inc.^(a)		12		3,132
Symantec Corp.		396		8,007
TripAdvisor Inc.^(a)(b)		48		2,784
Twilio Inc., Class A^(a)		52		3,010
Twitter Inc.^(a)		496		15,808
VeriSign Inc.^(a)		56		8,133
Wayfair Inc., Class A^(a)		24		2,612
Yelp Inc.^(a)		48		1,770
Zendesk Inc.^(a)		68		3,704
Zillow Group Inc., Class A^(a)		28		1,578
Zillow Group Inc., Class C, NVS^(a)		56		3,119

				1,534,765
Machinery — 0.2%
Cognex Corp.		80		4,222
Rockwell Automation Inc.		16		3,001
Roper Technologies Inc.		16		4,831

				12,054
Media — 0.1%
FactSet Research Systems Inc.		20		4,027


Office & Business Equipment — 0.1%
Xerox Corp.		112		2,908
Zebra Technologies Corp., Class A^(a)		32		4,414

				7,322
Pharmaceuticals — 0.1%
McKesson Corp.		28		3,517
Zoetis Inc.		36		3,113

				6,630
Real Estate — 0.1%
Jones Lang LaSalle Inc.		16		2,736


Real Estate Investment Trusts — 0.3%
Equinix Inc.		32		14,057
Iron Mountain Inc.		108		3,792

				17,849
Retail — 0.1%
Best Buy Co. Inc.		56		4,201
Copart Inc.^(a)		48		2,755

				6,956
Semiconductors — 9.3%
Advanced Micro Devices Inc.^(a)(b)		680		12,464
Analog Devices Inc.		148		14,229
Applied Materials Inc.		408		19,841
Cypress Semiconductor Corp.		216		3,847
Integrated Device Technology Inc.^(a)		60		2,066
Intel Corp.		2,016		96,970
IPG Photonics Corp.^(a)		8		1,312
KLA-Tencor Corp.		80		9,394
Lam Research Corp.		64		12,201
Marvell Technology Group Ltd.		104		2,216
Maxim Integrated Products Inc.		164		10,027
Microchip Technology Inc.		128		11,959
Micron Technology Inc.^(a)		556		29,351
Monolithic Power Systems Inc.		24		3,184
NVIDIA Corp.		468		114,594
ON Semiconductor Corp.^(a)		184		4,057


Security	Shares		Value

Semiconductors (continued)
Qorvo Inc.^(a)		56	$	4,579
QUALCOMM Inc.		872		55,886
Silicon Laboratories Inc.^(a)		28		2,667
Skyworks Solutions Inc.		96		9,080
Teradyne Inc.		92		3,979
Texas Instruments Inc.		468		52,098
Xilinx Inc.		168		12,108

				488,109
Software — 27.6%
2U Inc.^(a)		28		2,119
ACI Worldwide Inc.^(a)		80		2,067
Activision Blizzard Inc.		284		20,851
Acxiom Corp.^(a)		52		2,108
Adobe Systems Inc.^(a)		392		95,915
Akamai Technologies Inc.^(a)		120		9,031
ANSYS Inc.^(a)		56		9,457
Aspen Technology Inc.^(a)		40		3,832
athenahealth Inc.^(a)		16		2,411
Autodesk Inc.^(a)		148		19,009
Black Knight Inc.^(a)		56		2,892
Blackbaud Inc.		36		3,593
Box Inc., Class A^(a)		108		2,588
Broadridge Financial Solutions Inc.		56		6,327
CA Inc.		284		12,556
Cadence Design Systems Inc.^(a)		196		8,642
CDK Global Inc.		76		4,746
Cerner Corp.^(a)		116		7,201
Citrix Systems Inc.^(a)		112		12,317
Cloudera Inc.^(a)		92		1,232
CommVault Systems Inc.^(a)		36		2,336
Cornerstone OnDemand Inc.^(a)		48		2,371
Dun & Bradstreet Corp. (The)		28		3,525
Electronic Arts Inc.^(a)		148		19,055
Fair Isaac Corp.^(a)		20		4,029
Fidelity National Information Services Inc.		152		15,676
First Data Corp., Class A^(a)		220		5,117
Fiserv Inc.^(a)		244		18,417
Guidewire Software Inc.^(a)		52		4,482
HubSpot Inc.^(a)		28		3,475
Intuit Inc.		160		32,678
j2 Global Inc.		28		2,376
Jack Henry & Associates Inc.		48		6,466
Manhattan Associates Inc.^(a)		52		2,502
Medidata Solutions Inc.^(a)		40		2,972
Microsoft Corp.		6,576		697,582
MSCI Inc.		48		7,977
New Relic Inc.^(a)		36		3,517
Nuance Communications Inc.^(a)		216		3,190
Oracle Corp.		3,020		143,994
Paycom Software Inc.^(a)(b)		36		3,825
Pegasystems Inc.		32		1,779
Progress Software Corp.		44		1,619
PTC Inc.^(a)		96		8,823
RealPage Inc.^(a)		36		1,984
Red Hat Inc.^(a)		160		22,597
salesforce.com Inc.^(a)		627		85,993
ServiceNow Inc.^(a)		156		27,450
Splunk Inc.^(a)		124		11,916
SS&C Technologies Holdings Inc.		104		5,519
Synopsys Inc.^(a)		112		10,016


Security	Shares		Value

Software (continued)
Tableau Software Inc., Class A^(a)		60	$	6,184
Take-Two Interactive Software Inc.^(a)		52		5,877
Tyler Technologies Inc.^(a)		24		5,400
Ultimate Software Group Inc. (The)^(a)		24		6,645
Veeva Systems Inc., Class A^(a)		88		6,656
Verint Systems Inc.^(a)		48		2,155
VMware Inc., Class A^(a)		64		9,254
Workday Inc., Class A^(a)		128		15,875
Zynga Inc., Class A^(a)		436		1,653

				1,451,851
Telecommunications — 3.9%
Arista Networks Inc.^(a)		48		12,275
Ciena Corp.^(a)		96		2,438
Cisco Systems Inc.		3,900		164,931
CommScope Holding Co. Inc.^(a)		64		2,055
Juniper Networks Inc.		284		7,481
LogMeIn Inc.		40		3,242
Motorola Solutions Inc.		64		7,763
Zayo Group Holdings Inc.^(a)		68		2,522

				202,707
Transportation — 0.4%
Expeditors International of Washington Inc.		52		3,961
FedEx Corp.		20		4,917
United Parcel Service Inc., Class B		76		9,112
XPO Logistics Inc.^(a)		16		1,596

				19,586


Total Common Stocks — 99.2% (Cost: $4,866,527)				5,222,977


Security	Shares		Value

Short-Term Investments

Money Market Funds — 1.8%
BlackRock Cash Funds: Institutional, SL Agency Shares, 2.14%^(c)(d)(e)		51,044	$	51,059
BlackRock Cash Funds: Treasury, SL Agency Shares, 1.83%^(c)(d)		43,533		43,533

				94,592


Total Short-Term Investments — 1.8% (Cost: $94,589)				94,592


Total Investments in Securities — 101.0% (Cost: $4,961,116)				5,317,569

Other Assets, Less Liabilities — (1.0)%				(51,297	)


Net Assets — 100.0%			$	5,266,272

^(a)	Non-income producing security.

^(b)	All or a portion of this security is on loan.

^(c)	Affiliate of the Fund.

^(d)	Annualized 7-day yield as of period-end.

^(e)	All or a portion of this security was purchased with cash collateral received from loaned securities.

Investments in issuers considered to be affiliates of the Fund during the period ended July 31, 2018, for purposes of Section 2(a)(3) of the 1940 Act, were as follows:


Affiliated Issuer	Shares Held at 03/21/18	^(a)	Net Activity	Shares Held at 07/31/18		Value at 07/31/18		Income			Net Realized Gain (Loss)	^(b)		Change in Unrealized Appreciation (Depreciation)
BlackRock Cash Funds: Institutional, SL Agency Shares	—		51,044	51,044	$	51,059	$	22	^(c)	$	—		$	3
BlackRock Cash Funds: Treasury, SL Agency Shares	—		43,533	43,533		43,533		238			—			—

					$	94,592	$	260		$	—		$	3


	Level 1		Level 2		Level 3		Total
Investments
Assets
Common Stocks	$	5,222,977	$	—	$	—	$	5,222,977
Money Market Funds		94,592		—		—		94,592

	$	5,317,569	$	—	$	—	$	5,317,569

iShares U.S. ETF Trust (the “Trust”) is registered under the Investment Company Act of 1940, as amended (the “1940 Act”), as an open-end management investment company. The Trust is organized as a Delaware statutory trust and is authorized to have multiple series or portfolios.

These financial statements relate only to the following funds (each, a “Fund,” and collectively, the “Funds”):

The following significant accounting policies are consistently followed by each Fund in the preparation of its financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of increases and decreases in net assets from operations during the reporting period. Actual results could differ from those estimates. Each Fund is considered an investment company under U.S. GAAP and follows the accounting and reporting guidance applicable to investment companies.

Investment Transactions and Income Recognition: Investment transactions are accounted for on trade date. Realized gains and losses on investment transactions are determined using the specific identification method. Dividend income and capital gain distributions, if any, are recognized on the ex-dividend date, net of any foreign taxes withheld at source. Any taxes withheld that are reclaimable from foreign tax authorities are reflected in tax reclaims receivable. Distributions received by the Funds may include a return of capital that is estimated by management. Such amounts are recorded as a reduction of the cost of investments or reclassified to capital gains. Upon notification from issuers, some of the dividend income received from a real estate investment trust may be re-designated as a return of capital or capital gain. Non-cash dividends, if any, are recognized on the ex-dividend date and recorded as non-cash dividend income at fair value. Interest income is accrued daily.

Foreign Taxes: The Funds may be subject to foreign taxes (a portion of which may be reclaimable) on income, stock dividends, capital gains on investments, or certain foreign currency transactions. All foreign taxes are recorded in accordance with the applicable foreign tax regulations and rates that exist in the foreign jurisdictions in which each Fund invests. These foreign taxes, if any, are paid by each Fund and are reflected in its statement of operations as follows: foreign taxes withheld at source are presented as a reduction of income, foreign taxes on securities lending income are presented as a reduction of securities lending income, foreign taxes on stock dividends are presented as “other foreign taxes”, and foreign taxes on capital gains from sales of investments and foreign taxes on foreign currency transactions are included in their respective net realized gain (loss) categories. Foreign taxes payable or deferred as of July 31, 2018, if any, are disclosed in the statement of assets and liabilities.

In-kind Redemptions: For financial reporting purposes, in-kind redemptions are treated as sales of securities resulting in realized capital gains or losses to the Funds. Because such gains or losses are not taxable to the Funds and are not distributed to existing Fund shareholders, the gains or losses are reclassified from accumulated net realized gain (loss) to paid-in capital at the end of the Funds’ tax year. These reclassifications have no effect on net assets or net asset value per share.

Distributions: Dividends and distributions paid by each Fund are recorded on the ex-dividend dates. Distributions are determined on a tax basis and may differ from net investment income and net realized capital gains for financial reporting purposes. Dividends and distributions are paid in U.S. dollars and cannot be automatically reinvested in additional shares of the Funds.

Indemnifications: In the normal course of business, each Fund enters into contracts that contain a variety of representations that provide general indemnification. The Funds’ maximum exposure under these arrangements is unknown because it involves future potential claims against the Funds, which cannot be predicted with any certainty.

Investment Valuation Policies: Each Fund’s investments are valued at fair value (also referred to as “market value” within the financial statements) each day that the Fund’s listing exchange is open and, for financial reporting purposes, as of the report date should the reporting period end on a day that the Fund’s listing exchange is not open. U.S. GAAP defines fair value as the price a fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. A fund determines the fair value of its financial instruments using various independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). The BlackRock Global Valuation Methodologies Committee (the “Global Valuation Committee”) is the committee formed by management to develop global pricing policies and procedures and to oversee the pricing function for all financial instruments.

Fair Value Inputs and Methodologies: The following methods and inputs are used to establish the fair value of each Fund’s assets and liabilities:

If events (e.g., a company announcement, market volatility or a natural disaster) occur that are expected to materially affect the value of an investment, or in the event that application of these methods of valuation results in a price for an investment that is deemed not to be representative of the market value of such investment, or if a price is not available, the investment will be valued by the Global Valuation Committee, in accordance with policies approved by the Board as reflecting fair value (“Fair Valued Investments”). The fair valuation approaches that may be used by the Global Valuation Committee include market approach, income approach and the cost approach. Valuation techniques used under these approaches take into consideration inputs that include but are not limited to (i) attributes specific to the investment; (ii) the principal market for the investment; (iii) the customary participants in the principal market for the investment; (iv) data assumptions by market participants for the investment, if reasonably available; (v) quoted prices for similar investments in active markets; and (vi) other inputs, such as future cash flows, interest rates, yield curves, volatilities, prepayment speeds, loss severities, credit risks and/or default rates.

The Global Valuation Committee employs various methods for calibrating valuation approaches for investments where an active market does not exist, including regular due diligence of the Trust’s pricing vendors, regular reviews of key inputs and assumptions, transactional back-testing or disposition analysis to compare unrealized gains and losses to realized gains and losses, reviews of missing or stale prices and large movements in market values, and reviews of any market related activity. The pricing of all Fair Valued Investments is subsequently reported to the Board on a quarterly basis.

Fair Value Hierarchy: Various inputs are used in determining the fair value of financial instruments. These inputs to valuation techniques are categorized into a fair value hierarchy consisting of three broad levels for financial reporting purposes as follows:

The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). Accordingly, the degree of judgement exercised in determining fair value is greatest for instruments categorized in Level 3. The inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the fair value hierarchy classification is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The fair value hierarchy for each Fund’s investments is included in its schedule of investments.

Changes in valuation techniques may result in transfers into or out of an assigned level within the hierarchy. In accordance with the Trust’s policy, transfers between different levels of the fair value hierarchy are deemed to have occurred as of the beginning of the reporting period. The categorization of a value determined for financial instruments is based on the pricing transparency of the financial instruments and is not necessarily an indication of the risks associated with investing in those securities.

Securities Lending: Each Fund may lend its securities to approved borrowers, such as brokers, dealers and other financial institutions. The borrower pledges and maintains with the Fund collateral consisting of cash, an irrevocable letter of credit issued by an approved bank, or securities issued or guaranteed by the U.S. government. The initial collateral received by each Fund is required to have a value of at least 102% of the current market value of the loaned securities for securities traded on U.S. exchanges and a value of at least 105% for all other securities. The collateral is maintained thereafter at a value equal to at least 100% of the current value of the securities on loan. The market value of the loaned securities is determined at the close of each business day of the Fund and any additional required collateral is delivered to the Fund or excess collateral is returned by the Fund, on the next business day. During the term of the loan, each Fund is entitled to all distributions made on or in respect of the loaned securities but does not receive interest income on securities received as collateral. Loans of securities are terminable at any time and the borrower, after notice, is required to return borrowed securities within the standard time period for settlement of securities transactions.

As of July 31, 2018, any securities on loan were collateralized by cash and/or U.S. government obligations. Cash collateral received was invested in money market funds managed by BlackRock Fund Advisors (“BFA”), the Funds’ investment adviser, or its affiliates and is disclosed in the schedules of investments. Any non-cash collateral received cannot be sold, re-invested or pledged by the Fund, except in the event of borrower default. The securities on loan for each Fund, if any, are also disclosed in its schedule of investments. The market value of any securities on loan as of July 31, 2018 and the value of the related cash collateral are disclosed in the statements of assets and liabilities.

Securities lending transactions are entered into by a fund under Master Securities Lending Agreements (each, an “MSLA”) which provide the right, in the event of default (including bankruptcy or insolvency) for the non-defaulting party to liquidate the collateral and calculate a net exposure to the defaulting party or request additional collateral. In the event that a borrower defaults, the fund, as lender, would offset the market value of the collateral received against the market value of the securities loaned. The value of the collateral is typically greater than the market value of the securities loaned, leaving the lender with a net amount payable to the defaulting party. However, bankruptcy or insolvency laws of a particular jurisdiction may impose restrictions on or prohibitions against such a right of offset in the event of an MSLA counterparty’s bankruptcy or insolvency. Under the MSLA, absent an event of default, the borrower can resell or re-pledge the loaned securities, and the fund can reinvest cash collateral received in connection with loaned securities.

The following table is a summary of the securities lending agreements by counterparty which are subject to offset under an MSLA as of July 31, 2018:

The risks of securities lending include the risk that the borrower may not provide additional collateral when required or may not return the securities when due. To mitigate these risks, each Fund benefits from a borrower default indemnity provided by BlackRock, Inc. (“BlackRock”). BlackRock’s indemnity allows for full replacement of the securities loaned if the collateral received does not cover the value of the securities loaned in the event of borrower default. Each Fund could incur a loss if the value of an investment purchased with cash collateral falls below the market value of the loaned securities or if the value of an investment purchased with cash collateral falls below the value of the original cash collateral received.

Investment Advisory Fees: Pursuant to an Investment Advisory Agreement with the Trust, BFA manages the investment of each Fund’s assets. BFA is a California corporation indirectly owned by BlackRock. Under the Investment Advisory Agreement, BFA is responsible for substantially all expenses of the Funds, except (i) interest and taxes; (ii) brokerage commissions and other expenses connected with the execution of portfolio transactions; (iii) distribution fees; (iv) the advisory fee payable to BFA; and (v) litigation expenses and any extraordinary expenses (in each case as determined by a majority of the independent trustees).

For its investment advisory services to each Fund, BFA is entitled to an annual investment advisory fee, accrued daily and paid monthly by the Funds, based on the average daily net assets of each Fund as follows:

Distributor: BlackRock Investments, LLC, an affiliate of BFA, is the distributor for each Fund. Pursuant to the distribution agreement, BFA is responsible for any fees or expenses for distribution services provided to the Funds.

Securities Lending: The U.S. Securities and Exchange Commission (the “SEC”) has issued an exemptive order which permits BlackRock Institutional Trust Company, N.A. (“BTC”),an affiliate of BFA, to serve as securities lending agent for the Funds, subject to applicable conditions. As securities lending agent, BTC bears all operational costs directly related to securities lending. Each Fund is responsible for fees in connection with the investment of cash collateral received for securities on loan in a money market fund managed by BFA, or its affiliates, however, BTC has agreed to reduce the amount of securities lending income it receives in order to effectively limit the collateral investment fees each Fund bears to an annual rate of 0.04% (the “collateral investment fees”). Securities lending income is equal to the total of income earned from the reinvestment of cash collateral (excluding collateral investment fees), net of fees and other payments to and from borrowers of securities. Each Fund retains a portion of securities lending income and remits the remaining portion to BTC as compensation for its services as securities lending agent.

Pursuant to a securities lending agreement, each Fund retains 71.5% of securities lending income (which excludes collateral investment fees) and the amount retained can never be less than 65% of the total of securities lending income plus the collateral investment fees.

In addition, commencing the business day following the date that the aggregate securities lending income plus the collateral investment fees generated across all 1940 Act iShares exchange-traded funds (the “iShares ETF Complex”) in a given calendar year exceeds the aggregate securities lending income generated across the iShares ETF Complex in the calendar year 2013, each Fund, pursuant to a securities lending agreement, will retain for the remainder of that calendar year 75% of securities lending income and the amount retained can never be less than 65% of the total of securities lending income plus the collateral investment fees.

The share of securities lending income earned by each Fund is shown as securities lending income – affiliated – net in its statement of operations. For the period ended July 31, 2018, the Funds paid BTC the following amounts for securities lending agent services:

Officers and Trustees: Certain officers and/or trustees of the Trust are officers and/or trustees of BlackRock or its affiliates.

Other Transactions: The PNC Financial Services Group, Inc. is the largest stockholder and an affiliate of BlackRock for 1940 Act purposes.

The iShares Evolved U.S. Financials ETF is expected to receive a payment from BFA to compensate the Fund for an operating error that occurred during the period. The payment is shown as other assets in the Statements of Assets and Liabilities.

Each Fund may invest its positive cash balances in certain money market funds managed by BFA or an affiliate. The income earned on these temporary cash investments is shown as dividends – affiliated in the statements of operations.

It is possible that, from time to time, BlackRock and/or funds managed by BFA or an affiliate (collectively, “Affiliates”) may purchase and hold shares of a Fund. Affiliates reserve the right, subject to compliance with applicable law, to sell into the market or redeem in Creation Units through an authorized participant at any time some or all of the shares of a Fund acquired for their own accounts. A large sale or redemption of shares of a Fund by Affiliates could significantly reduce the asset size of the Fund, which

might have an adverse effect on the Fund. As of July 31, 2018, the number of affiliated accounts that individually represent more than 10% ownership of a Fund’s total shares outstanding and the aggregate percentage of net assets represented by such holdings were as follows:

For the period ended July 31, 2018, purchases and sales of investments, excluding in-kind transactions and short-term investments, were as follows:

Each Fund is treated as an entity separate from the Trust’s other funds for federal income tax purposes. It is the policy of each Fund to qualify as a regulated investment company by complying with the provisions applicable to regulated investment companies, as defined under Subchapter M of the Internal Revenue Code of 1986, as amended, and to annually distribute substantially all of its ordinary income and any net capital gains (taking into account any capital loss carryforwards) sufficient to relieve it from all, or substantially all, federal income and excise taxes. Accordingly, no provision for federal income taxes is required.

Management has analyzed tax laws and regulations and their application to the Funds as of July 31, 2018, inclusive of the open tax return years, and does not believe that there are any uncertain tax positions that require recognition of a tax liability in the Funds’ financial statements.

U.S. GAAP requires that certain components of net assets be adjusted to reflect permanent differences between financial and tax reporting. These reclassifications have no effect on net assets or NAV per share. As of July 31, 2018, the following permanent differences attributable to the use of equalization and realized gains (losses) from in-kind redemptions, were reclassified to the following accounts:

As of July 31, 2018, the tax components of accumulated net earnings (losses) were as follows:

^(a) The difference between book-basis and tax-basis unrealized gains (losses) was attributable primarily to the tax deferral of losses on wash sales.

As of July 31, 2018, the iShares Evolved U.S. Financials ETF had non-expiring capital loss carryforwards in the amount of $21,341 available to offset future realized capital gains.

As of July 31, 2018, gross unrealized appreciation and depreciation based on cost of investments (including short positions and derivatives, if any) for U.S. federal income tax purposes were as follows:

The Tax Cuts and Jobs Act (the “Act”) was enacted on December 22, 2017. Certain provisions of the Act were effective upon enactment with the remainder becoming effective for tax years beginning after December 31, 2017. Although the Act does not amend any provisions directly related to the qualification or taxation of regulated investment companies (“RICs”), the Act does change the taxation of entities in which some RICs invest, the tax treatment of income derived from those entities and the taxation of RIC shareholders. While management does not anticipate significant impact to the funds or to their shareholders, there is uncertainty in the application of certain provisions in the Act. Specifically, provisions in the Act may increase the amount of or accelerate the recognition of taxable income and may limit the deductibility of certain expenses by RICs. Until full clarity around these provisions is obtained, the impact on the Funds’ financial statements, if any, cannot be fully determined.

In the normal course of business, each Fund invests in securities or other instruments and may enter into certain transactions, and such activities subject the Fund to various risks, including, among others, fluctuations in the market (market risk) or failure of an issuer to meet all of its obligations. The value of securities or other instruments may also be affected by various factors, including, without limitation: (i) the general economy; (ii) the overall market as well as local, regional or global political and/or social instability; (iii) regulation, taxation or international tax treaties between various countries; or (iv) currency, interest rate or price fluctuations. Each Fund’s prospectus provides details of the risks to which the Fund is subject.

Market Risk: Market risk arises mainly from uncertainty about future values of financial instruments influenced by price, currency and interest rate movements. It represents the potential loss a fund may suffer through holding market positions in the face of market movements. A fund is exposed to market risk by its investment in equity, fixed income and/or financial derivative instruments or by its investment in underlying funds. The fair value of securities held by a fund may decline due to general market conditions, economic trends or events that are not specifically related to the issuers of the securities including local, regional or global political, social or economic instability or to factors that affect a particular industry or group of industries. The extent of a fund’s exposure to market risk is the market value of the investments held as shown in the fund’s schedule of investments.

Credit Risk: Credit risk is the risk that an issuer or guarantor of debt instruments or the counterparty to a financial transaction, including derivatives contracts, repurchase agreements or loans of portfolio securities, is unable or unwilling to make timely interest and/or principal payments or to otherwise honor its obligations. BFA and its affiliates manage counterparty credit risk by entering into transactions only with counterparties that they believe have the financial resources to honor their obligations and by monitoring the financial stability of those counterparties. Financial assets, which potentially expose a fund to issuer and counterparty credit risks, consist principally of financial instruments and receivables due from counterparties. The extent of a fund’s exposure to credit and counterparty risks with respect to those financial assets is approximated by their value recorded in its statement of assets and liabilities.

Concentration Risk: A diversified portfolio, where this is appropriate and consistent with a fund’s objectives, minimizes the risk that a price change of a particular investment will have a material impact on the NAV of a fund. The investment concentrations within each Fund’s portfolio are disclosed in its schedule of investments.

When a fund concentrates its investments in securities within a single or limited number of market sectors, it assumes the risk that economic, regulatory, political and social conditions affecting such sectors may have a significant impact on the fund and could affect the income from, or the value or liquidity of, the fund’s portfolio.

Capital shares are issued and redeemed by each Fund only in aggregations of a specified number of shares or multiples thereof (“Creation Units”) at NAV. Except when aggregated in Creation Units, shares of each Fund are not redeemable.

The consideration for the purchase of Creation Units of a fund in the Trust generally consists of the in-kind deposit of a designated portfolio of securities and a specified amount of cash. Certain funds in the Trust may be offered in Creation Units solely or partially for cash in U.S. dollars. Investors purchasing and redeeming Creation Units may pay a purchase transaction fee and a redemption transaction fee directly to State Street Bank and Trust Company, the Trust’s administrator, to offset transfer and other transaction costs associated with the issuance and redemption of Creation Units, including Creation Units for cash. Investors transacting in Creation Units for cash may also pay an additional variable charge to compensate the relevant fund for certain transaction costs (i.e., stamp taxes, taxes on currency or other financial transactions, and brokerage costs) and market impact expenses relating to investing in portfolio securities. Such variable charges, if any, are included in shares sold in the table above.

On June 16, 2016, investors in certain iShares funds (iShares Core S&P Small-Cap ETF, iShares Russell 1000 Growth ETF, iShares Core S&P 500 ETF, iShares Russell Mid-Cap Growth ETF, iShares Russell Mid-Cap ETF, iShares Russell Mid-Cap Value ETF, iShares Select Dividend ETF, iShares Morningstar Mid-Cap ETF, iShares Morningstar Large-Cap ETF, iShares U.S. Aerospace & Defense ETF and iShares U.S. Preferred Stock ETF) filed a class action lawsuit against iShares Trust, BlackRock,

Inc. and certain of its advisory affiliates, and certain directors/trustees and officers of the Funds (collectively, “Defendants”) in California State Court. The lawsuit alleges the Defendants violated federal securities laws by failing to adequately disclose in the prospectuses issued by the funds noted above the risks of using stop-loss orders in the event of a ‘flash crash’, such as the one that occurred on May 6, 2010. On September 18, 2017, the court issued a Statement of Decision holding that the Plaintiffs lack standing to assert their claims. On October 11, 2017, the court entered final judgment dismissing all of the Plaintiffs’ claims with prejudice. Plaintiffs have appealed the court’s decision.

Management has evaluated the impact of all subsequent events on the Funds through the date the financial statements were available to be issued and has determined that there were no subsequent events requiring adjustment or additional disclosure in the financial statements.

iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF,

iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Technology ETF

We have audited the accompanying statements of assets and liabilities, including the schedules of investments, of iShares Evolved U.S. Discretionary Spending ETF, iShares Evolved U.S. Consumer Staples ETF, iShares Evolved U.S. Financials ETF, iShares Evolved U.S. Healthcare Staples ETF, iShares Evolved U.S. Innovative Healthcare ETF, iShares Evolved U.S. Media and Entertainment ETF and iShares Evolved U.S. Technology ETF (seven of the funds constituting iShares U.S. ETF Trust, hereafter collectively referred to as the “Funds”) as of July 31, 2018, the related statements of operations and changes in net assets, including the related notes, and the financial highlights for the period March 21, 2018 (commencement of operations) through July 31, 2018 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of each of the Funds as of July 31, 2018, and the results of each of their operations, changes in each of their net assets, and each of their financial highlights for the period March 21, 2018 (commencement of operations) through July 31, 2018 in conformity with accounting principles generally accepted in the United States of America.

These financial statements are the responsibility of the Funds’ management. Our responsibility is to express an opinion on the Funds’ financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Funds in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of July 31, 2018 by correspondence with the custodian, transfer agent and brokers; when replies were not received from brokers, we performed other auditing procedures. We believe that our audits provide a reasonable basis for our opinions.

We have served as the auditor of one or more BlackRock investment companies since 2000.

For corporate shareholders, the percentage of dividend income paid during the fiscal year ended July 31, 2018 that qualified for the dividends-received deductions were as follows:

The following maximum amounts are hereby designated as qualified dividend income for individuals for the fiscal year ended July 31, 2018:

Under Section 15(c) of the Investment Company Act of 1940 (the “1940 Act”), the Trust’s Board of Trustees (the “Board”), including a majority of Trustees who are not “interested persons” of the Trust (as that term is defined in the 1940 Act) (the “Independent Trustees”), is required annually to consider and approve the Investment Advisory Contract between the Trust and BFA (the “Advisory Contract”) on behalf of the Fund. The Independent Trustees requested, and BFA provided, such information as the Independent Trustees, with advice from independent counsel, deemed reasonably necessary to evaluate the Advisory Contract. At a meeting on May 11, 2018, a committee composed of all of the Independent Trustees (the “15(c) Committee”), with independent counsel, met with management and reviewed and discussed information provided in response to initial requests of the 15(c) Committee and/or their independent counsel, and requested certain additional information, which management agreed to provide. At these meetings, the 15(c) Committee reviewed and discussed information provided in response to the 15(c) Committee’s initial requests, and requested certain additional information, which management agreed to provide. At a meeting held on May 24, 2018, management presented additional information to the Board relating to the continuance of the Advisory Contract, including information requested by the 15(c) Committee during its initial meeting. The Board, including the Independent Trustees, reviewed and discussed such information at length. The Independent Trustees requested from management certain additional information, which management agreed to provide. At a meeting held on June 12-14, 2018, the Board, including the Independent Trustees, reviewed the additional information provided by management in response to these requests. After extensive discussions, the Board, including all of the Independent Trustees, approved the continuance of the Advisory Contract for the Fund, based on a review of qualitative and quantitative information provided by BFA. The Board noted its satisfaction with the extent and quality of information provided and its frequent interactions with management, as well as the detailed responses and other information provided by BFA. The Independent Trustees were advised by their independent counsel throughout the process, including about the legal standards applicable to their review. In approving the Advisory Contract for the Fund, the Board, including the Independent Trustees, considered various factors, including: (i) the expenses and performance of the Fund; (ii) the nature, extent and quality of the services provided by BFA; (iii) the costs of services provided to the Fund and profits realized by BFA and its affiliates; (iv) economies of scale; (v) the fees and services provided for other comparable funds/accounts managed by BFA and its affiliates; and (vi) other benefits to BFA and/or its affiliates. The material factors, no one of which was controlling, and conclusions that formed the basis for the Board, including the Independent Trustees, to approve the Advisory Contract are discussed below.

Expenses and Performance of the Fund – The Board reviewed statistical information prepared by Broadridge Financial Solutions Inc. (“Broadridge”), an independent provider of investment company data, regarding the expense ratio components, including gross and net total expenses, fees and expenses of another fund in which the Fund invests (if applicable), and waivers/reimbursements (if applicable) of the Fund in comparison with the same information for other ETFs (including, where applicable, funds sponsored by an “at cost” service provider), objectively selected by Broadridge as comprising the Fund’s applicable peer group pursuant to Broadridge’s proprietary ETF methodology (the “Peer Group”). The Board was provided with a detailed description of the proprietary ETF methodology used by Broadridge to determine the Fund’s Peer Group. The Board further noted that due to the limitations in providing comparable funds in the Peer Group, the statistical information provided in Broadridge’s report may or may not provide meaningful direct comparisons to the Fund in all instances.

The Board also noted that the investment advisory fee rate and overall expenses (net of waivers and reimbursements) for the Fund were lower than the median of the investment advisory fee rates and overall expenses (net of waivers and reimbursements) of the funds in its Peer Group, excluding iShares funds.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

Based on this review, the other factors considered at the meeting, and their general knowledge of ETF pricing, the Board concluded that the investment advisory fee rate and expense level and the historical performance of the Fund supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Nature, Extent and Quality of Services Provided by BFA – Based on management’s representations, including information about recent and proposed enhancements to the iShares business, including with respect to capital markets support and analysis, technology, portfolio management, product design and quality, compliance and risk management, global public policy and other services, the Board expected that there would be no diminution in the scope of services required of or provided by BFA under the Advisory Contract for the coming year as compared to the scope of services provided by BFA during prior years. In reviewing the scope of these services, the Board considered BFA’s investment philosophy and experience, noting that BFA and its affiliates have committed significant resources over time, including during the past year, to support the iShares funds and their shareholders. The Board also considered BFA’s compliance program and its compliance record with respect to the Fund. In that regard, the Board noted that BFA reports to the Board about portfolio management and compliance matters on a periodic basis in connection with regularly scheduled meetings of the Board, and on other occasions as necessary and appropriate, and has provided information and made relevant officers and other employees of BFA (and its affiliates) available as needed to provide further assistance with these matters. The Board also reviewed the background and experience of the persons responsible for the day-to-day management of the Fund, as well as the resources available to them in managing the Fund. In addition to the above considerations, the Board reviewed and considered detailed presentations regarding BFA’s investment performance, investment and risk management processes and strategies provided at the June 12-14, 2018 meeting and throughout the year, and matters related to BFA’s portfolio compliance policies and procedures.

Based on review of this information, and the performance information discussed above, the Board concluded that the nature, extent and quality of services provided to the Fund under the Advisory Contract supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Costs of Services Provided to the Fund and Profits Realized by BFA and its Affiliates – The Board reviewed information about the profitability of the iShares complex to BlackRock, based on the fees payable to BFA and its affiliates (including fees under the Advisory Contract), and other sources of revenue and expense to BFA and its affiliates from the iShares funds’ operations for the last calendar year. The Board did not consider the profitability of the Fund to BFA and its affiliates since the Fund had not commenced operations as of December 31, 2017. The Board reviewed BlackRock’s profitability methodology for the iShares funds, noting that the 15(c) Committee and the Board had focused on the methodology and profitability presentation during their meetings. The Board noted that the 15(c) Committee had focused on the methodology and profitability presentation during its meetings. The Board further noted that it considered the supplemental information the 15(c) Committee requested, which BlackRock provided, regarding the methodology. The Board discussed the sources of direct and ancillary revenue with management, including the revenues to BTC, a BlackRock

affiliate, from securities lending by the iShares funds. The Board noted that it expects to receive profitability information from BFA on at least an annual basis following the Fund’s launch and thus be in a position to evaluate whether any new or additional breakpoints or other adjustments in Fund fees would be appropriate.

Economies of Scale – The Board reviewed information regarding potential economies of scale or other efficiencies that may result from increases in the Fund’s assets, noting that the issue of economies of scale had been focused on by the 15(c) Committee and the Board during their meetings and addressed by management. The 15(c) Committee and the Board received information regarding BlackRock’s historical profitability, including BFA’s and its affiliates’ costs in providing services. The cost information distinguished, among other things, between fixed and variable costs, and showed how the level of fixed and variable costs, as well as the nature of such costs, may impact the existence or size of scale benefits. The 15(c) Committee and the Board reviewed information provided by BFA regarding the sharing of scale benefits with the iShares funds through various means, including, as applicable, through relatively low fee rates established at inception, breakpoints, waivers, or other fee reductions, as well as through additional investment in the iShares business and the provision of improved or additional infrastructure and services to the iShares funds and their shareholders. The Board noted that the Advisory Contract for the Fund did not provide for breakpoints in the Fund’s investment advisory fee rate as the assets of the Fund increase. However, the Board noted that a breakpoint structure for the Fund may be appropriate should material economies of scale exist in the future that are not otherwise shared, and that it would continue to monitor the sharing of economies of scale to determine the appropriateness of adding breakpoints in the future.

Based on this review of the sharing of scale benefits, as well as the other factors considered at the meeting, the Board concluded that the information concerning the sharing of scale benefits supported the Board’s approval of the continuance of the Advisory Contract for the coming year.

Fees and Services Provided for Other Comparable Funds/Accounts Managed by BFA and its Affiliates – The Board received and considered information regarding the investment advisory/management fee rates for other funds/accounts in the U.S. for which BFA (or its affiliates) provides investment advisory/management services, including open-end funds registered under the 1940 Act (including sub-advised funds), collective trust funds, and institutional separate accounts (collectively, the “Other Accounts”), and acknowledged BFA’s assertion that the iShares funds are fundamentally different investment vehicles from the Other Accounts. The Board noted that BFA and its affiliates do not manage Other Accounts with a similar investment strategy or investment mandate as the Fund. The Board further noted that BFA provided the Board with detailed information regarding how the Other Accounts generally differ from the Fund, including in terms of the different and generally more extensive services provided to the Fund, as well as other significant differences. In that regard, the Board considered that the pricing of services to institutional clients is typically based on a number of factors beyond the nature and extent of the specific services to be provided and often depends on the overall relationship between the client and its affiliates and the adviser and its affiliates. In addition, the Board considered the relative complexity and inherent risks and challenges of managing and providing other services to the Fund, as a publicly traded ETF, as compared to the Other Accounts, particularly those that are institutional clients, in light of differing regulatory requirements and client-imposed mandates. The Board also acknowledged management’s assertion that, for certain iShares funds, and for client segmentation purposes, BlackRock has launched an iShares fund that may provide a similar investment exposure at a lower investment advisory fee rate. The Board also considered the “all-inclusive” nature of the Fund’s advisory fee structure, and the Fund’s expenses borne by BFA under this arrangement. The Board noted that the investment advisory fee rate under the Advisory Contract for the Fund was generally higher than the investment advisory/management fee rates for certain of the Other Accounts (particularly institutional clients) and concluded that the differences appeared to be consistent with the factors discussed.

Other Benefits to BFA and/or its Affiliates – Except as noted below, the Board did not consider the “fallout” benefits or ancillary revenue to be received by BFA and/or its affiliates in connection with the services to be provided to the Fund by BFA, since the Fund has not commenced operations as of December 31, 2017. The Board reviewed the “fallout” benefits or ancillary revenue received by BFA and/or its affiliates in connection with the services provided to other iShares funds by BFA, such as payment of revenue to BTC, the securities lending agent to the iShares funds, for loaning portfolio securities (which was included in the profit margins reviewed by the Board pursuant to BFA’s profitability methodology), and payment of advisory fees and/or administration fees to BFA (or its affiliates) in connection with any investments by the iShares funds in other funds for which BFA (or its affiliates) provides investment advisory services and/or administration services. The Board also noted the revenue received by BFA and/or its affiliates pursuant to an agreement that permits a service provider to use certain portions of BlackRock’s technology platform to service accounts managed by BFA and/or its affiliates, including the iShares funds. The Board noted that BFA generally does not use soft dollars or consider the value of research or other services that may be provided to BFA (including its affiliates) in selecting brokers for portfolio transactions for the iShares funds. The Board further noted that any portfolio transactions on behalf of the iShares funds placed through a BFA affiliate or purchased from an underwriting syndicate in which a BFA affiliate participates (including associated commissions) are reported to the Board pursuant to Rule 17e-1 or Rule 10f-3, as applicable, under the 1940 Act. The Board concluded that any such ancillary benefits would not be disadvantageous to the Fund and thus would not alter the Board’s conclusion with respect to the appropriateness of approving the continuance of the Advisory Contract for the coming year.

Conclusion – Based on a review of the factors described above, as well as such other factors as deemed appropriate by the Board, the Board, including all of the Independent Trustees, determined that the Fund’s investment advisory fee rate under the Advisory Contract does not constitute a fee that is so disproportionately large as to bear no reasonable relationship to the services rendered and that could not have been the product of arm’s-length bargaining, and concluded to approve the continuance of the Advisory Contract for the coming year.

continuance of the Advisory Contract, including information requested by the 15(c) Committee during its initial meeting. The Board, including the Independent Trustees, reviewed and discussed such information at length. The Independent Trustees requested from management certain additional information, which management agreed to provide. At a meeting held on June 12-14, 2018, the Board, including the Independent Trustees, reviewed the additional information provided by management in response to these requests. After extensive discussions, the Board, including all of the Independent Trustees, approved the continuance of the Advisory Contract for the Fund, based on a review of qualitative and quantitative information provided by BFA. The Board noted its satisfaction with the extent and quality of information provided and its frequent interactions with management, as well as the detailed responses and other information provided by BFA. The Independent Trustees were advised by their independent counsel throughout the process, including about the legal standards applicable to their review. In approving the Advisory Contract for the Fund, the Board, including the Independent Trustees, considered various factors, including: (i) the expenses and performance of the Fund; (ii) the nature, extent and quality of the services provided by BFA; (iii) the costs of services provided to the Fund and profits realized by BFA and its affiliates; (iv) economies of scale; (v) the fees and services provided for other comparable funds/accounts managed by BFA and its affiliates; and (vi) other benefits to BFA and/or its affiliates. The material factors, no one of which was controlling, and conclusions that formed the basis for the Board, including the Independent Trustees, to approve the Advisory Contract are discussed below.

The Board also noted that the investment advisory fee rate and overall expenses (net of waivers and reimbursements)for the Fund were lower than the median of the investment advisory fee rates and overall expenses (net of waivers and reimbursements) of the funds in its Peer Group, excluding iShares funds.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

increase. However, the Board noted that a breakpoint structure for the Fund may be appropriate should material economies of scale exist in the future that are not otherwise shared, and that it would continue to monitor the sharing of economies of scale to determine the appropriateness of adding breakpoints in the future.

comparable funds/accounts managed by BFA and its affiliates; and (vi) other benefits to BFA and/or its affiliates. The material factors, no one of which was controlling, and conclusions that formed the basis for the Board, including the Independent Trustees, to approve the Advisory Contract are discussed below.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

Accounts”), and acknowledged BFA’s assertion that the iShares funds are fundamentally different investment vehicles from the Other Accounts. The Board noted that BFA and its affiliates do not manage Other Accounts with a similar investment strategy or investment mandate as the Fund. The Board further noted that BFA provided the Board with detailed information regarding how the Other Accounts generally differ from the Fund, including in terms of the different and generally more extensive services provided to the Fund, as well as other significant differences. In that regard, the Board considered that the pricing of services to institutional clients is typically based on a number of factors beyond the nature and extent of the specific services to be provided and often depends on the overall relationship between the client and its affiliates and the adviser and its affiliates. In addition, the Board considered the relative complexity and inherent risks and challenges of managing and providing other services to the Fund, as a publicly traded ETF, as compared to the Other Accounts, particularly those that are institutional clients, in light of differing regulatory requirements and client-imposed mandates. The Board also acknowledged management’s assertion that, for certain iShares funds, and for client segmentation purposes, BlackRock has launched an iShares fund that may provide a similar investment exposure at a lower investment advisory fee rate. The Board also considered the “all-inclusive” nature of the Fund’s advisory fee structure, and the Fund’s expenses borne by BFA under this arrangement. The Board noted that the investment advisory fee rate under the Advisory Contract for the Fund was generally higher than the investment advisory/management fee rates for certain of the Other Accounts (particularly institutional clients) and concluded that the differences appeared to be consistent with the factors discussed.

Peer Group. The Board further noted that due to the limitations in providing comparable funds in the Peer Group, the statistical information provided in Broadridge’s report may or may not provide meaningful direct comparisons to the Fund in all instances.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

iShares fund that may provide a similar investment exposure at a lower investment advisory fee rate. The Board also considered the “all-inclusive” nature of the Fund’s advisory fee structure, and the Fund’s expenses borne by BFA under this arrangement. The Board noted that the investment advisory fee rate under the Advisory Contract for the Fund was generally higher than the investment advisory/management fee rates for certain of the Other Accounts (particularly institutional clients) and concluded that the differences appeared to be consistent with the factors discussed.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

in other funds for which BFA (or its affiliates) provides investment advisory services and/or administration services. The Board also noted the revenue received by BFA and/or its affiliates pursuant to an agreement that permits a service provider to use certain portions of BlackRock’s technology platform to service accounts managed by BFA and/or its affiliates, including the iShares funds. The Board noted that BFA generally does not use soft dollars or consider the value of research or other services that may be provided to BFA (including its affiliates) in selecting brokers for portfolio transactions for the iShares funds. The Board further noted that any portfolio transactions on behalf of the iShares funds placed through a BFA affiliate or purchased from an underwriting syndicate in which a BFA affiliate participates (including associated commissions) are reported to the Board pursuant to Rule 17e-1 or Rule 10f-3, as applicable, under the 1940 Act. The Board concluded that any such ancillary benefits would not be disadvantageous to the Fund and thus would not alter the Board’s conclusion with respect to the appropriateness of approving the continuance of the Advisory Contract for the coming year.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

considered detailed presentations regarding BFA’s investment performance, investment and risk management processes and strategies provided at the June 12-14, 2018 meeting and throughout the year, and matters related to BFA’s portfolio compliance policies and procedures.

to bear no reasonable relationship to the services rendered and that could not have been the product of arm’s-length bargaining, and concluded to approve the continuance of the Advisory Contract for the coming year.

Because the Fund had not commenced operations as of December 31, 2017, the Board did not review any performance information for the Fund.

and profitability presentation during its meetings. The Board further noted that it considered the supplemental information the 15(c) Committee requested, which BlackRock provided, regarding the methodology. The Board discussed the sources of direct and ancillary revenue with management, including the revenues to BTC, a BlackRock affiliate, from securities lending by the iShares funds. The Board noted that it expects to receive profitability information from BFA on at least an annual basis following the Fund’s launch and thus be in a position to evaluate whether any new or additional breakpoints or other adjustments in Fund fees would be appropriate.

The Premium/Discount Information section is intended to present information about the differences between the daily market price on secondary markets for shares of a fund and that fund’s NAV. NAV is the price at which a fund issues and redeems shares. It is calculated in accordance with the standard formula for valuing mutual fund shares. The “Market Price” of a fund generally is determined using the midpoint between the highest bid and the lowest ask on the primary securities exchange on which shares of such fund are listed for trading, as of the time that a fund’s NAV is calculated. A fund’s Market Price may be at, above or below its NAV. The NAV of a fund will fluctuate with changes in the value of its portfolio holdings. The Market Price of a fund will fluctuate in accordance with changes in its NAV, as well as market supply and demand.

Premiums or discounts are the differences (expressed as a percentage) between the NAV and Market Price of a fund on a given day, generally at the time the NAV is calculated. A premium is the amount that a fund is trading above the reported NAV, expressed as a percentage of the NAV. A discount is the amount that a fund is trading below the reported NAV, expressed as a percentage of the NAV.

Premium/discount information for the Funds covering the most recently completed calendar year and the most recently completed calendar quarters since that year (or since the Fund began trading, if shorter) is publicly accessible, free of charge, at www.iShares.com.

The following information shows the frequency of distributions of premiums and discounts for the Funds for the immediately preceding five calendar years (or from the date a Fund began trading on the secondary market, if less than five years) through the date of the most recent calendar quarter-end. Each line in each table shows the number of trading days in which the Fund traded within the premium/discount range indicated. Premium/discount ranges with no trading days are omitted. The number of trading days in each premium/discount range is also shown as a percentage of the total number of trading days in the period covered by each table. All data presented here represents past performance, which cannot be used to predict future results.

The Board of Trustees has responsibility for the overall management and operations of the Funds, including general supervision of the duties performed by BFA and other service providers. Each Trustee serves until he or she resigns, is removed, dies, retires or becomes incapacitated. The President, Chief Compliance Officer, Treasurer and Secretary shall each hold office until their successors are chosen and qualify, and all other officers shall hold office until he or she resigns or is removed. Trustees who are not “interested persons” (as defined in the 1940 Act) of the Trust are referred to as independent trustees (“Independent Trustees”).

The registered investment companies advised by BFA or its affiliates (the “BlackRock-advised Funds”) are organized into one complex of closed-end funds, two complexes of open-end funds and one complex of exchange-traded funds (“Exchange-Traded Fund Complex”) (each, a “BlackRock Fund Complex”). Each Fund is included in the BlackRock Fund Complex referred to as the Exchange-Traded Fund Complex. Each Trustee also serves as a Director of iShares, Inc. and a Trustee of iShares Trust, and, as a result, oversees all of the funds within the Exchange-Traded Fund Complex which consists of 358 funds as of July 31, 2018. With the exception of Robert S. Kapito, Mark K. Wiedman, Charles Park, Martin Small and Benjamin Archibald, the address of each Trustee and officer is c/o BlackRock, Inc., 400 Howard Street, San Francisco, CA 94105. The address of Mr. Kapito, Mr. Wiedman, Mr. Park, Mr. Small, and Mr. Archibald is c/o BlackRock, Inc., Park Avenue Plaza, 55 East 52nd Street, New York, NY 10055. The Board has designated Cecilia H. Herbert as its Independent Board Chair. Additional information about the Funds’ Trustees and officers may be found in the Funds’ combined Statement of Additional Information, which is available without charge, upon request, by calling toll-free 1-800-iShares (1-800-474-2737).

Shareholders can sign up for email notifications announcing that the shareholder report or prospectus has been posted on the iShares website at www.iShares.com. Once you have enrolled, you will no longer receive prospectuses and shareholder reports in the mail.

Householding is an option available to certain fund investors. Householding is a method of delivery, based on the preference of the individual investor, in which a single copy of certain shareholder documents can be delivered to investors who share the same address, even if their accounts are registered under different names. Please contact your broker-dealer if you are interested in enrolling in householding and receiving a single copy of prospectuses and other shareholder documents, or if you are currently enrolled in householding and wish to change your householding status.

The iShares Funds file their complete schedule of portfolio holdings with the SEC for the first and third quarters of each fiscal year on Form N-Q. The iShares Funds’ Forms N-Q are available on the SEC’s website at www.sec.gov and may be reviewed and copied at the SEC’s Public Reference Room in Washington, D.C.Information on the operation of the Public Reference Room may be obtained by calling 1-800-SEC-0330. The iShares Funds also disclose their complete schedule of portfolio holdings on a daily basis on the iShares website at www.iShares.com.

A description of the policies and procedures that iShares Funds use to determine how to vote proxies relating to portfolio securities and information about how the iShares Funds voted proxies relating to portfolio securities during the most recent twelve-month period ending June 30 is available without charge, upon request (1) by calling toll-free 1-800-474-2737; (2) on the iShares website at www.iShares.com; and (3) on the SEC website at www.sec.gov.

For more information visit www.iShares.com or call 1-800-iShares (1-800-474-2737)


		This report is intended for the Funds’ shareholders. It may not be distributed to prospective investors unless it is preceded or accompanied by the current prospectus.
		Investing involves risk, including possible loss of principal.
		The iShares Funds are distributed by BlackRock Investments, LLC (together with its affiliates, “BlackRock”).
		©2018 BlackRock, Inc. All rights reserved. iSHARES and BLACKROCK are registered trademarks of BlackRock, Inc. or its subsidiaries. All other marks are the property of their respective owners.

The registrant has adopted a code of ethics, as of the end of the period covered by this report, applicable to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. During the period covered by this report, the code of ethics was amended to clarify an inconsistency in to whom persons covered by the code should report suspected violations of the code. The amendment clarifies that such reporting should be made to BlackRock’s General Counsel, and retains the alternative option of anonymous reporting following “whistleblower” policies. Other non-material changes were also made in connection with this amendment. During the period covered by this report, there have been no waivers granted under the code of ethics. The registrant undertakes to provide a copy of the code of ethics to any person upon request, without charge, by calling 1-800-474-2737.

The registrant’s Board of Trustees has determined that the registrant has more than one audit committee financial expert, as that term is defined under Item 3(b) and 3(c), serving on its audit committee. The audit committee financial experts serving on the registrant’s audit committee are Charles A. Hurty, Richard L. Fagnani (began serving on the audit committee effective as of June 20, 2017 and was designated as an audit committee financial expert serving on the audit

committee effective as of September 15, 2017), John E. Kerrigan, and Madhav V. Rajan, all of whom are independent, as that term is defined under Item 3(a)(2).

The principal accountant fees disclosed in items 4(a), 4(b), 4(c), 4(d) and 4(g) are for the seven series of the registrant for which the fiscal year-end is July 31, 2018 (the “Funds”), and whose annual financial statements are reported in Item 1.

(2) There were no services described in (b) through (d) above that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

(a) The registrant is a listed issuer as defined in Rule 10A-3 under the Exchange Act of 1934 and has a separately-designated standing audit committee established in accordance with Section 3(a)(58)(A) of the Exchange Act of 1934.

The registrant’s audit committee members are Charles A. Hurty, Richard L. Fagnani (began serving on the audit committee effective as of June 20, 2017), John E. Kerrigan, and Madhav V. Rajan.

There were no material changes to the procedures by which shareholders may recommend nominees to the registrant’s Board of Trustees.

(a) The President (the registrant’s Principal Executive Officer) and Treasurer and Chief Financial Officer (the registrant’s Principal Financial Officer) have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) are effective as of a date within 90 days of the filing date of this report, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the Investment Company Act of 1940 and Rules 13a-15(b) or 15d-15(b) under the Exchange Act of 1934.

(b) There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.


		Cumulative Total Returns
		Since
		Inception
Fund NAV		2.34%
Fund Market		2.38
S&P Total Market Index^TM		4.51


Actual					Hypothetical 5% Return

Beginning Account Value (03/21/18)^(a)	Ending Account Value (07/31/18)		Expenses Paid During the Period^(b)		Beginning Account Value (02/01/18)		Ending Account Value (07/31/18)		Expenses Paid During the Period ^(b)		Annualized Expense Ratio
$ 1,000.00	$	1,023.40	$	0.66	$	1,000.00	$	1,023.90	$	0.90		0.18	%


		Cumulative Total Returns
		Since
		Inception
Fund NAV		7.96%
Fund Market		7.92
S&P Total Market Index^TM		4.51


Actual					Hypothetical 5% Return

Beginning Account Value (03/21/18)^(a)	Ending Account Value (07/31/18)		Expenses Paid During the Period ^(b)		Beginning Account Value (02/01/18)		Ending Account Value (07/31/18)		Expenses Paid During the Period ^(b)		Annualized Expense Ratio
$ 1,000.00	$	1,079.60	$	0.68	$	1,000.00	$	1,023.90	$	0.90		0.18	%


		Cumulative Total Returns
		Since
		Inception
Fund NAV		(1.40)%
Fund Market		(1.44)
S&P Total Market Index^TM		4.51


	Page
Market Overview		5
Fund Summary		6
About Fund Performance		20
Shareholder Expenses		20
Schedules of Investments		21
Financial Statements
Statements of Assets and Liabilities		44
Statements of Operations		46
Statements of Changes in Net Assets		48
Financial Highlights		50
Notes to Financial Statements		57
Report of Independent Registered Public Accounting Firm		65
Important Tax Information (Unaudited)		66
Board Review and Approval of Investment Advisory Contract		67
Supplemental Information		80
Trustee and Officer Information		82
General Information		84
Glossary of Terms Used in this Report		85


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Consumer Staples ETF


6		2 0 1 8 I S H A R E S A N N U A L R E P O R T T O S H A R E H O L D E R S


Sector		Percent of Total Investments^(a)
Food		28.3%
Beverages		27.8
Agriculture		13.5
Retail		11.3
Cosmetics & Personal Care		9.6
Household Products & Wares		2.3
Packaging & Containers		1.7
Pharmaceuticals		1.4
Chemicals		1.1
Other (each representing less than 1%)		3.0


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Discretionary Spending ETF


Security		Percent of Total Investments^(a)
Amazon. com Inc.		11.5%
Home Depot Inc. (The)		9.5
Walmart Inc.		5.8
Costco Wholesale Corp.		4.2
Procter & Gamble Co. (The)		4.0
McDonald’s Corp.		3.8
NIKE Inc., Class B		3.8
TJX Companies Inc. (The)		3.1
Lowe’s Companies Inc.		2.9
Target Corp.		2.3


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Financials ETF


Sector		Percent of Total Investments^(a)
Banks		47.1%
Insurance		21.4
Diversified Financial Services		15.8
Commercial Services		4.5
Health Care - Services		3.4
Manufacturing		2.1
Savings & Loans		1.7
Software		1.6
Other (each representing less than 1%)		2.4


Security		Percent of Total Investments^(a)
JPMorgan Chase & Co.		4.8%
Bank of America Corp.		4.8
Wells Fargo & Co.		4.5
U. S. Bancorp		3.3
Goldman Sachs Group Inc. (The)		2.9
Berkshire Hathaway Inc., Class B		2.5
Morgan Stanley		2.3
General Electric Co.		2.1
American Express Co.		2.1
Charles Schwab Corp. (The)		2.0


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Healthcare Staples ETF


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Innovative Healthcare ETF


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Media and Entertainment ETF


ALLOCATION BY SECTOR
Sector		Percent of Total Investments^(a)
Media		65.6%
Software		11.7
Internet		7.7
Entertainment		7.6
Toys, Games & Hobbies		3.3
Telecommunications		2.5
Other (each representing less than 1%)		1.6


TEN LARGEST HOLDINGS
Security		Percent of Total Investments^(a)
Walt Disney Co. (The)		7.0%
Twenty-First Century Fox Inc., Class B		6.0
Twenty-First Century Fox Inc., Class A		6.0
Comcast Corp., Class A		5.8
Netflix Inc.		5.2
CBS Corp., Class B		5.1
Activision Blizzard Inc.		5.0
Electronic Arts Inc.		4.6
Charter Communications Inc., Class A		4.5
Viacom Inc., Class B		4.4


Fund Summary as of July 31, 2018		iShares^® Evolved U.S. Technology ETF


	iShares Evolved U.S. Consumer Staples ETF			iShares Evolved U.S. Discretionary Spending ETF			iShares Evolved U.S. Financials ETF				iShares Evolved U.S. Healthcare Staples ETF

ASSETS
Investments in securities, at value (including securities on loan)^(a):
Unaffiliated^(b)		$	3,551,047		$	5,336,661		$	4,862,674			$	5,446,087
Affiliated^(c)			210,374			58,999			39,373				50,730
Receivables:
Securities lending income — Affiliated			8			36			—				16
Dividends			4,649			3,999			3,145				3,680
Other assets			—			—			14,501				—

Total assets			3,766,078			5,399,695			4,919,693				5,500,513


LIABILITIES
Collateral on securities loaned, at value			10,253			29,999			—				4,309
Payables:
Investment advisory fees			585			816			740				830

Total liabilities			10,838			30,815			740				5,139


NET ASSETS		$	3,755,240		$	5,368,880		$	4,918,953			$	5,495,374


NET ASSETS CONSIST OF:
Paid-in capital		$	3,703,772		$	4,956,981		$	4,938,160			$	4,960,601
Undistributed net investment income			25,529			3,903			6,588				4,865
Accumulated net realized gain (loss)			8,485			465			(21,490	)			(13	)
Net unrealized appreciation (depreciation)			17,454			407,531			(4,305	)			529,921

NET ASSETS		$	3,755,240		$	5,368,880		$	4,918,953			$	5,495,374


Shares outstanding			150,000			200,000			200,000				200,000

Net asset value		$	25.03		$	26.84		$	24.59			$	27.48

Shares authorized			Unlimited			Unlimited			Unlimited				Unlimited

Par value			None			None			None				None


^(a)Securities loaned, at value		$	9,953		$	29,529		$	—			$	4,237
^(b)Investments, at cost — Unaffiliated		$	3,533,593		$	4,929,133		$	4,866,979			$	4,916,167
^(c)Investments, at cost — Affiliated		$	210,374		$	58,996		$	39,373			$	50,729


	iShares Evolved U.S. Innovative Healthcare ETF			iShares Evolved U.S. Media and Entertainment ETF			iShares Evolved U.S. Technology ETF

ASSETS
Investments in securities, at value (including securities on loan)^(a):
Unaffiliated^(b)		$	5,166,419		$	5,095,161		$	5,222,977
Affiliated^(c)			133,590			561,016			94,592
Receivables:
Investments sold			131,020			—			—
Securities lending income — Affiliated			76			108			17
Dividends			5,002			3,325			558

Total assets			5,436,107			5,659,610			5,318,144


LIABILITIES
Collateral on securities loaned, at value			80,086			381,983			51,056
Payables:
Investments purchased			149,697			—			—
Investment advisory fees			783			829			816

Total liabilities			230,566			382,812			51,872


NET ASSETS		$	5,205,541		$	5,276,798		$	5,266,272


NET ASSETS CONSIST OF:
Paid-in capital		$	4,918,256		$	4,979,943		$	4,907,809
Undistributed net investment income			4,177			6,833			1,866
Accumulated net realized gain			26,905			13,093			144
Net unrealized appreciation			256,203			276,929			356,453

NET ASSETS		$	5,205,541		$	5,276,798		$	5,266,272


Shares outstanding			200,000			200,000			200,000

Net asset value		$	26.03		$	26.38		$	26.33

Shares authorized			Unlimited			Unlimited			Unlimited

Par value			None			None			None


^(a)Securities loaned, at value		$	79,272		$	378,408		$	49,646
^(b)Investments, at cost — Unaffiliated		$	4,910,224		$	4,818,270		$	4,866,527
^(c)Investments, at cost — Affiliated		$	133,582		$	560,978		$	94,589


		iShares			iShares			iShares			iShares
		Evolved			Evolved			Evolved			Evolved
		U.S. Consumer			U.S. Discretionary			U.S. Financials			U.S. Healthcare
		Staples ETF	^(a)		Spending ETF	^(a)		ETF	^(a)		Staples ETF	^(a)


INVESTMENT INCOME
Dividends — Unaffiliated	$	60,274	^(b)	$	25,645		$	31,112		$	19,030
Dividends — Affiliated		581			178			218			230
Securities lending income — Affiliated — net		8			57			—			25
Foreign taxes withheld		—			—			(4	)		—

Total investment income		60,863			25,880			31,326			19,285


EXPENSES
Investment advisory fees		2,911			3,261			3,081			3,292

Total expenses		2,911			3,261			3,081			3,292

Net investment income		57,952			22,619			28,245			15,993


REALIZED AND UNREALIZED GAIN (LOSS)
Net realized gain (loss) from:
Investments — Unaffiliated		10,971			464			(21,490	)		(13	)
Investments — Affiliated		—			1			—			—
In-kind redemptions — Unaffiliated		(10,151	)		—			—			—

Net realized gain (loss)		820			465			(21,490	)		(13	)

Net change in unrealized appreciation/depreciation on:
Investments — Unaffiliated		17,454			407,528			(4,305	)		529,920
Investments — Affiliated		—			3			—			1

Net change in unrealized appreciation/depreciation		17,454			407,531			(4,305	)		529,921

Net realized and unrealized gain (loss)		18,274			407,996			(25,795	)		529,908

NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS	$	76,226		$	430,615		$	2,450		$	545,901


	iShares Evolved U.S. Consumer Staples ETF			iShares Evolved U.S. Discretionary Spending ETF			iShares Evolved U.S. Financials ETF			iShares Evolved U.S. Healthcare Staples ETF

	Period From			Period From			Period From			Period From
		03/21/18	^(a)		03/21/18	^(a)		03/21/18	^(a)		03/21/18	^(a)
		to 07/31/18			to 07/31/18			to 07/31/18			to 07/31/18


INCREASE (DECREASE) IN NET ASSETS

OPERATIONS
Net investment income	$	57,952		$	22,619		$	28,245		$	15,993
Net realized gain (loss)		820			465			(21,490	)		(13	)
Net change in unrealized appreciation/depreciation		17,454			407,531			(4,305	)		529,921

Net increase in net assets resulting from operations		76,226			430,615			2,450			545,901


DISTRIBUTIONS TO SHAREHOLDERS
From net investment income		(32,423	)		(18,716	)		(21,657	)		(11,128	)

Decrease in net assets resulting from distributions to shareholders		(32,423	)		(18,716	)		(21,657	)		(11,128	)


CAPITAL SHARE TRANSACTIONS
Net increase in net assets derived from capital share transactions		3,711,437			4,956,981			4,938,160			4,960,601


NET ASSETS
Total increase in net assets		3,755,240			5,368,880			4,918,953			5,495,374

End of period	$	3,755,240		$	5,368,880		$	4,918,953		$	5,495,374

Undistributed net investment income included in net assets at end of period	$	25,529		$	3,903		$	6,588		$	4,865


	iShares Evolved U.S. Innovative Healthcare ETF			iShares Evolved U.S. Media and Entertainment ETF			iShares Evolved U.S. Technology ETF

		Period From			Period From			Period From
		03/21/18	^(a)		03/21/18	^(a)		03/21/18	^(a)
		to 07/31/18			to 07/31/18			to 07/31/18


INCREASE (DECREASE) IN NET ASSETS

OPERATIONS
Net investment income	$	21,582		$	18,568		$	12,558
Net realized gain		26,905			13,093			144
Net change in unrealized appreciation/depreciation		256,203			276,929			356,453

Net increase in net assets resulting from operations		304,690			308,590			369,155


DISTRIBUTIONS TO SHAREHOLDERS
From net investment income		(17,405	)		(11,735	)		(10,692	)

Decrease in net assets resulting from distributions to shareholders		(17,405	)		(11,735	)		(10,692	)


CAPITAL SHARE TRANSACTIONS
Net increase in net assets derived from capital share transactions		4,918,256			4,979,943			4,907,809


NET ASSETS
Total increase in net assets		5,205,541			5,276,798			5,266,272

End of period	$	5,205,541		$	5,276,798		$	5,266,272

Undistributed net investment income included in net assets at end of period	$	4,177		$	6,833		$	1,866



Net asset value, beginning of period	$	24.62

Net investment income^(b)		0.31	^(c)
Net realized and unrealized gain^(d)		0.26

Net increase from investment operations		0.57


Distributions^(e)
From net investment income		(0.16	)

Total distributions		(0.16	)


Net asset value, end of period	$	25.03


Total Return
Based on net asset value		2.34	%^(f)


Ratios to Average Net Assets
Total expenses		0.18	%^(g)

Net investment income		3.58	%^(c)(g)


Supplemental Data
Net assets, end of period (000)	$	3,755

Portfolio turnover rate^(h)		0	%^(f)


			iShares Evolved U.S. Discretionary Spending ETF

			Period From
			03/21/18	^(a)
			to 07/31/18



Net asset value, beginning of period	$	24.95

Net investment income^(b)		0.12
Net realized and unrealized gain^(c)		1.86

Net increase from investment operations		1.98


Distributions^(d)
From net investment income		(0.09	)

Total distributions		(0.09	)


Net asset value, end of period	$	26.84


Total Return
Based on net asset value		7.96	%^(e)


Ratios to Average Net Assets
Total expenses		0.18	%^(f)

Net investment income		1.25	%^(f)


Supplemental Data
Net assets, end of period (000)	$	5,369

Portfolio turnover rate^(g)		0	%^(e)



Net asset value, beginning of period	$	24.98

Net investment income^(b)		0.15
Net realized and unrealized loss^(c)		(0.43	)

Net decrease from investment operations		(0.28	)


Distributions^(d)
From net investment income		(0.11	)

Total distributions		(0.11	)


Net asset value, end of period	$	24.59


Total Return
Based on net asset value		(1.11	)%^(e)(f)


Ratios to Average Net Assets
Total expenses		0.18	%^(g)

Net investment income		1.65	%^(g)


Supplemental Data
Net assets, end of period (000)	$	4,919

Portfolio turnover rate^(h)		13	%^(e)



Net asset value, beginning of period	$	24.86

Net investment income^(b)		0.08
Net realized and unrealized gain^(c)		2.60

Net increase from investment operations		2.68


Distributions^(d)
From net investment income		(0.06	)

Total distributions		(0.06	)


Net asset value, end of period	$	27.48


Total Return
Based on net asset value		10.77	%^(e)


Ratios to Average Net Assets
Total expenses		0.18	%^(f)

Net investment income		0.87	%^(f)


Supplemental Data
Net assets, end of period (000)	$	5,495

Portfolio turnover rate^(g)		0	%^(e)



Net asset value, beginning of period	$	24.97

Net investment income^(b)		0.11
Net realized and unrealized gain^(c)		1.04

Net increase from investment operations		1.15


Distributions^(d)
From net investment income		(0.09	)

Total distributions		(0.09	)


Net asset value, end of period	$	26.03


Total Return
Based on net asset value		4.62	%^(e)


Ratios to Average Net Assets
Total expenses		0.18	%^(f)

Net investment income		1.25	%^(f)


Supplemental Data
Net assets, end of period (000)	$	5,206

Portfolio turnover rate^(g)		3	%^(e)


			iShares Evolved U.S. Media and Entertainment ETF

			Period From
			03/21/18	^(a)
			to 07/31/18



Net asset value, beginning of period	$	25.05

Net investment income^(b)		0.10
Net realized and unrealized gain^(c)		1.29

Net increase from investment operations		1.39


Distributions^(d)
From net investment income		(0.06	)

Total distributions		(0.06	)


Net asset value, end of period	$	26.38


Total Return
Based on net asset value		5.54	%^(e)


Ratios to Average Net Assets
Total expenses		0.18	%^(f)

Net investment income		1.04	%^(f)


Supplemental Data
Net assets, end of period (000)	$	5,277

Portfolio turnover rate^(g)		0	%^(e)


			iShares Evolved U.S. Technology ETF

			Period From
			03/21/18	^(a)
			to 07/31/18



Net asset value, beginning of period	$	24.89

Net investment income^(b)		0.06
Net realized and unrealized gain^(c)		1.43

Net increase from investment operations		1.49


Distributions^(d)
From net investment income		(0.05	)

Total distributions		(0.05	)


Net asset value, end of period	$	26.33


Total Return
Based on net asset value		6.00	%^(e)


Ratios to Average Net Assets
Total expenses		0.18	%^(f)

Net investment income		0.70	%^(f)


Supplemental Data
Net assets, end of period (000)	$	5,266

Portfolio turnover rate^(g)		0	%^(e)